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CHAPTER 1 - INTRODUCTION 
The topic of this dissertation covers the study of acute cell injury phenomenon.  
During my appointed schedule in an Emergency Room as a physician, I have faced and 
treated many acute injuries which manifest in the form of stroke, myocardial infarction, 
or acute kidney failure in patients.  Acute injuries have clearly identifiable damage 
mechanisms, as opposed to chronic injuries like Alzheimer’s or Parkinson’s diseases, 
where the cause of the disease is essentially unknown. In most of the cases, we could 
sustain the life of the patients.  However, we could not prevent the progression of tissue 
death after acute injuries.  These clinical conditions that we mentioned have resisted 
many attempts at therapies.  The overall failures of therapies to prevent cell death 
brings our lab to develop a new approach to acute cell injury in the form of a 
mathematical theory.  This theory derived from the research of acute cell injury, 
particularly in brain ischemia and reperfusion (I/R) presented in the mathematical 
model.  We abstract cell injury to consist of the action of two variables D and S.  We 
define variable D as the total damage caused by the injury, and variable S as the total 
induced stress response.  My goal in this Dissertation is to undertake the very first 
attempt to estimate the variables D and S.  Moreover, we will evaluate the goodness of 
fit of the theory based on the D and S measurements from the experiments.  We use 
the rat model of the global brain I/R to test the estimated measurements of D and S. 
This Dissertation will explore the background of the brain I/R reviewing the failure 
of many efforts in stopping the cell death process after brain I/R, known as 
neuroprotection.  Next, I will present the theory, and then propose my hypotheses.  I will 
provide the three Aims of the project: (1) To estimate D by levels of protein aggregation 
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after brain I/R, (2) to estimate S by changes in mRNA levels on polysomes after brain 
I/R, and (3) That the estimates of D and S can be fit by the math theory of acute cell 
injury.  I will present experimental designs, and methods in every aims and result.  
Finally, this dissertation will end with the discussion of how well the data in the 
experiment fit the proposed theory, the limitations of this work, and future directions. 
1.1 Brain Ischemia and Reperfusion 
Ischemia is a condition where the tissue has low or no blood flow resulting in a 
reduced level of oxygen and glucose in the tissue.  After the ischemia, the return of 
normal blood flow to the tissue is called reperfusion.  In the brain, two forms of 
pathological ischemia are known as global and focal brain ischemia.  Ischemia in the 
whole brain is known as global brain ischemia, which may result from the consequence 
of cardiac arrest event.  On the other hand, stroke or focal brain ischemia happens 
when there is an occlusion of the artery as a cause of an emboli or rupture in the artery. 
Stroke, cardiac arrest, and resuscitation have a high incidence from the brain I/R 
manifestation. In the United States, around 1,200,000 people are suffered from stroke 
every year. Stroke causes 20% mortality and 80% morbidity1.  However, cardiac arrests 
occur in 750,000 individuals in the United States annually2.  The latter causes a higher 
mortality rate of 80%, which most of the mortality (50-70%) is related to the brain 
damage3.  Both conditions create not only enormous financial burden including health 
care and research costs, but also social costs including loss of economic productivity, 
disruption of families and suffering of people.  For instance, the cost of stroke is 
estimated to be 50 billion US dollars per year in both of financial and social costs4. 
However, brain I/R research has shown a partial success in controlling hypertension 
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and obesity, as its risk factors.  The number of stroke and cardiac arrest events have 
reduced over the past years5.  To date, there are only a few treatments for patients with 
stroke or cardiac arrest.  We will discuss in this chapter the mechanism of the brain I/R 
and the failure of neuroprotection as the treatment option.  The therapies aim to stop 
neuronal death as the brain I/R outcome.  The theory of acute cell injury gives new 
insights, not only about the nature of cell death, but also related to the failing of 
neuroprotection. 
1.1.1 Brain I/R damage 
Brain I/R causes two forms of neuronal death known as necrosis and delayed 
neuronal death (DND)6-12.  In a prolonged stroke which lasts around six to eight hours or 
cardiac arrest which is happening for more than 30 minutes, necrosis of brain tissue 
occurs13-15.  However, there is no neuronal death in a shorter brain I/R duration mainly 
after ~15 minutes of stroke or 3-5 minutes of cardiac arrest.  When short insults are 
happening in the brain, it will serve as protection to the brain from the longer insults.  
This situation is known as ischemic preconditioning or ischemic tolerance16-18.  If the 
duration of the brain I/R is moderate, the cell takes a longer time to die, after reperfusion 
has initiated, and this is the DND.  In this case, neuronal death appears in hours or days 
after the ischemic insults15, 19.  In a rat model, CA1 type neurons in hippocampus die 72 
hours after 10 minutes of global brain ischemic insult, while another neuronal type in the 
same brain region known as CA3 neurons survive20-22.  We used this rat brain I/R model 
in this Dissertation, as described below.  Ischemic stroke is of two types.  Transient 
stroke has ischemia followed by reperfusion.  A permanent stroke may occur in the case 
of no reperfusion.  However, both temporary and permanent stroke develop a necrotic 
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core in the brain tissue.  The tissue around the core, termed as penumbra, will die by 
DND mechanism long after the ischemic insult.  This process could variably appear in 
days, weeks or months and ends with a wider lesion.  The neurological deficits driven 
by this process are usually severe23-28.  Currently, it is still not understood why DND 
process occurs after brain I/R.  The theory proposed in this Dissertation suggests a new 
explanation of DND to be caused by injury dynamics and not molecular pathways. 
1.1.2 Molecular mechanisms 
There are a lot of detailed researches of cell and molecular events in brain 
ischemia field. Searching the term “cerebral ischemia” as a keyword provides 124,064 
citations by August 15, 2017, in PubMed.  Neurons revealed many molecular changes 
after brain ischemia, a situation called as “multifactorial” injury process.  The term of 
“multifactorial” is also used for explaining another form of acute cell injury, particularly 
trauma and poisoning.  Since much is known about brain changes after an ischemic 
insult, here I will only review the major pathways activated in brain after I/R.  The 
pathways inaugurate with the loss of ATP.  Since ATP has main job of setting ion 
gradients in neurons, loss of ATP in ischemia is followed by the equilibration of ion 
between neurons and extracellular space.  This process also includes the changes in 
tonicity, ion activity, and pH inside of neurons.  With reperfusion, oxygen and glucose 
return to altered brain cells and cause free radicals activation (also called reactive 
oxygen species, ROS) and many other forms of damage.  However, some known 
ischemia activated molecular changes protect the neurons, including the unfolded 
protein response and heat shock response to safeguard the protein from further 
damage.  Antioxidant response is also played a role in protecting the neurons5. The 
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protective pathways are generally called stress responses.  
The major consequence of global brain ischemia is the loss blood flow.  As a 
result, there will be no transport of glucose or oxygen to the cell.  The main effect then is 
rapids loss of ATP in brain cells.  It is reported that ATP concentration in brain 
deteriorate promptly to zero after 7 minutes of ischemia29.  Subsequently, it stops all 
ATP- dependent metabolic processes.  For the neuron, the primary ATP-dependent 
function is to maintain the ion gradients between inside and outside of the cell10.  
Furthermore, the loss of energy causes the inhibition of Na+-K+ ATPase and Ca2+-
ATPases which cause the movement of ions down to concentration gradients.  The 
substantial concentration ratio caused by Ca2+ is 10,000:130, from extracellular to the 
cytoplasm.  The large influx of Ca2+ is the primary damaging agent inside the neuron.  If 
ischemia exists over an extended period of time, equilibrate Na+ and K+ ions also 
equilibrate and develop a net water influx.  The outcome of this event will end to a 
neuronal membrane lysis which will leads to immediate neuronal death called necrosis 
(Figure 1).  
For moderate ischemia times, Ca2+ influx results in additional significant 
damages. It leads to various enzymes activations including calpain proteases, 
phospholipases, and DNAses that degrade proteins31, 32, lipids33, and DNA34, 
respectively.  Degradation of lipids leads to altered cell membrane properties and to 
arachidonic acid accumulation that can make prostaglandins33.  Ca2+ induces nitric 
oxide (NO) synthases activation that will result in vessels vasodilatation.  However, an 
excess concentration of NO will cause free radical damage35.  On the other hand, during 
the loss of blood flow, the production of ATP will shift to glycolysis that produces excess 
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lactic acid in brain tissue that contributes to a further damage by altering pH of cells36. 
Reperfusion following the brain ischemia will result in returning of the oxygen and 
glucose to the cell. In about ten to thirty minutes of reperfusion, mitochondria will return 
to oxidative synthesis of ATP12.  However, oxygen re-exposure is destructive due to the 
free radical ROS production which will compound the previous damage from 
ischemia12,37,38.  Various ROS has been detected after brain I/R including nitric oxide, 
peroxidized lipids39, mitochondrial ROS40, and others from water12.  The free radicals 
can impair the whole cell apparatus functions such as membranes, proteins, DNA, and 
RNA.  Figure 1 summarizes major pathways of ischemia, the “ischemic cascade”. 
 
Figure 1: Ischemic “Cascade” 
Other numerous changes have been identified after brain I/R.  Some examples 
include apoptotic pathways activation such as caspase 341-43 and mitochondrial protein 
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Bcl and Bax44-46.  It is also reported there are swelling of endoplasmic reticulum and 
Golgi apparatus47-49, shrinkage of cell nucleus7, 50, 51, the disintegration of cytoskeleton 
structure52, dissociation of neuronal polysomes and inhibition of protein synthesis53-55, 
as well as loss of mitochondrial fission and fusion function56,57.  All of these changes 
have their individual time course.  The activation of each pathway depends on the 
length of ischemia, as well as the type of neurons studied. In addition, it sometimes 
depends on which type of species is considered. In most of the cases, it is still unknown 
whether the change is due to a physiologic reaction to ischemia, or is a form of cell 
damage. 
Various genes changes occur after brain I/R.  Based on microarray studies, 
hundreds  to  thousands of genes undergo up-regulation and downregulation  
process 58-65.  Similar to the damage, many factors are affecting the changes of the 
genes.  Many genes are activated as a cell stress responses including heat shock66-70, 
unfolded protein response (UPR)71-76 , anti-oxidant genes77-80, NF-kB pathway81, 82, DNA 
repair pathways34, 83-86, and pro-anabolic pathways like PPAR gamma87-90, to help cells 
recover after I/R damage.  
DND was thought to be the same as apoptosis. However, DND and apoptosis 
have distinct appearance morphologically7, 50, 51.  Among all of the enzymes, caspases, 
the main proteins involve in apoptosis, are only one of the thousands of molecular 
changes in neurons after brain I/R. Inhibitors of apoptosis can stop neuronal death in 
some animal models of brain I/R but do not alter the outcome in the human brain I/R91.  
All changes listed above are thought to make the “ischemic cascade” (Figure 1). 
This idea of the cascade is like dominoes, one hitting the next, to eventually cause a cell 
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death event such as apoptosis or necrosis.  Almost all clinical trials of neuroprotection 
were performed based on the attempt to inhibit one of the pathways in the ischemic 
cascade. However, if brain I/R causes a cascade, a drug should stop the cascade at 
some point in the diagram and prevent cell death. Below I will summarize how every 
clinical trial which is developed based on ischemic cascade failed in improving the 
outcome in humans. 
1.2 Failure of Neuroprotection after Brain Ischemia 
As previously described, neuroprotection targets to stop ischemic cascade at 
some point in the cell death pathways. By 2006, there were 114 drugs tested in stroke 
clinical trials to achieve neuroprotection.  Of all of those 114 clinical trials, they all failed. 
This failure was summarized by O’Collins et al. in 200691. This section gives summary 
of O’Collins et al. paper.  
The paper gives a three-page table to classify drugs tested in categories: 
excitotoxicity, anti-inflammatory, antioxidant, anti-apoptotic/regeneration, 
calcium/adrenergic/hypertensive agents, thrombolytic, nootropic, fluid regulation, 
oxygen delivery, and other.  Each category consists many drugs which were thought to 
work in a pathway in ischemic cascade to stop progression to cell death.  In conclusion, 
the authors state “no relationship was found between mechanism and efficacy” for 
drugs tested.  Also very important to this Dissertation, the authors say:  
“No particular drug mechanism distinguished itself on the basis of superior 
efficacy in animal models of focal ischemia. This may reflect the multifaceted 
nature of the sequelae of ischemic stroke and suggest a role for combination 
therapy to target multiple processes. Alternately, it might suggest that our 
conception of stroke needs reformulation. A tendency to exclusively frame drug 
activity in terms of the dominant schema of stroke damage (eg. excitotoxicity, 
free radical damage), coupled with the sometimes arbitrary attribution of a drug 
mechanism to one of several nonmutually exclusive groupings, might distract 
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from other paradigms with greater explanatory power, thus hindering the 
development of more effective treatments.” 
This quote is essential for this Dissertation. It says that a new way to study cell 
injury might be critical to overcoming the failure of neuroprotection. This Dissertation will 
consider a new “paradigm” of cell injury. I will discuss how it has a “greater explanatory 
power” to explain (1) the cause of cell death, and (2) how to make neuroprotection 
function properly. 
1.3 General Theory of Acute Cell Injury 
Drs. DeGracia, ZF Huang, and S. Huang formulated the nonlinear dynamical 
theory of acute cell injury in 201292.  The theory is shown by presenting two nonlinear 
ordinary differential equation (ODE) systems: 
n
D
D Dn n
D
n
S
S Sn n
S
dD v k D
dt S
dS v k S
dt D
  
  
 (1) 
The theory described how the total damage, D, and total induced stress 
response, S, change as a function of time and of parameters v, k, , and n. This theory 
can be easily explained by understanding four postulates: 
1. D and S form a network of damage and protective influences. 
2. The dynamics of D and S formation rate follow Hill functions. 
3. D and S are exponentially driven by I and –I, respectively. 
4. Decay from the attractor state, (D*, S*), is a function of |D* -S* |. 
The four are explained below. There are additional two more postulates which 
will be explained in Chapter 4 but introduced now: 
5. The velocity parameter v is constant equal to 1. 
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6. The decay parameter k is constant equal to 1. 
1.3.1 D and S form a network of damage and protective influences 
From previous research on brain I/R reviewed above, it showed some changes 
caused by ischemia damage the brain cells, but others protect neurons. Damage is to 
be thought of as non-physiological molecules in the cell, or of physiological molecules 
outside normal concentration ranges. For example, free radical damage to proteins is 
not common in healthy neurons37, 40, 93. Ca2+ ion has a low concentration (10-9 M) in the 
cytoplasm under normal condition, but in ischemia increases to hundreds of 
micromolar94-98. Many damages occur in the brain I/R. All taken together is defined as 
D, total induced damage. 
Protective changes caused by stress response pathways are programmed in 
cellular genes. Some examples involve heat shock response to refold unfolded proteins 
in cytoplasm53.  Unfolded protein response protects against unfolded proteins in 
endoplasmic reticulum72.  Transcription factor NrF2 activates genes for enzymes to 
eliminate ROS, for example peroxidases and glutathione metabolism99.  Some 
protection responses present in cell do not require gene activation.  Taurine system 
uses anion channels to extrude taurine to keep isotonic condition in cell when under 
hypertonic conditions of ischemia100-102. Similar to D, all protective changes add 
together give S, the total induced stress response. 
As stated, D and S defines all damaging and protective influences after acute 
injury. One more important feature of D and S is how it considers the many changes of 
D and S in making a network of pro-death and pro-survival forces.  For example, 
peroxidase enzyme can eliminate reactive oxygen species (ROS) from the cell. 
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However, ROS can interact with the peroxidase enzyme and cause free radical damage 
to inhibit protein function.  The ROS may come from pathway of iron called Fenton 
reaction93, 103, 104: 
Fe2+ + H2O2 ----> Fe3+ + .OH + OH- 
This reaction shows separate pathways, protein denaturation, and ROS reaction, 
to interact.  Many examples of pathways interacting with each other can also be 
considered.  Pathways are not distinct from each other but form network of interactions. 
In brain I/R acute cell injury, the network influences are of two types only: to 
destroy cell (D) or to protect cell (S).  Then we add all destructive influences and add all 
protective forces and determine the greater.  The acute theory of cell injury states when 
harmful impacts are higher than protective (D > S), the cell will die. If protective 
influences greater than destructive damage (S > D) then the cell will live. 
We cannot know all interactions of all pathways. The theory simplifies these 
situations, so we only know how D and S change in time. However, we need always to 
understand these terms refer to a complex network of molecular pathway interactions. 
1.3.2 The dynamics of D and S and Hill functions 
We simplify pathway complexity by following totals, D and S to change in time, 
called dynamics. Dynamics are to be studied using ODEs of D and S change in time. 
The theory makes formation rates of D and S follow S-shaped curves. S-shaped curves 
give the threshold parameter, , where effect is 50%. We do not know  beforehand, 
but assume there is the threshold amount of D, D, to inhibit S by 50%. There is also a 
threshold amount of S, S, to inhibit D by 50%. Then the rate of formation equal to Hill 
functions that give S-shaped curves: 
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n
D
D n n
D
n
S
S n n
S
dD v
dt S
dS v
dt D
  
  
 (2) 
Parameter n is Hill coefficient, typically called “cooperativity” for example in 
hemoglobin O2 binding curve.  Parameter n tells how strong the interaction is.  In the 
cell injury theory, n is measure of how strong is the pathways interaction in a network.  
The v parameters are the velocity of formation of D and S. Above in postulate 5 this was 
said as vD = vS = 1.  Making v a constant is, as mentioned, a problem, but is simplifying 
assumption for now. 
Eq. (2) is not correct, giving only the rate of formation of D and S.  There must be 
the rate of decay also so final ODE is net rate = rate of formation minus rate of decay.  
The theory gives rate of decay as exponential, like radioactive decay equation with 
decay constant k.  As with v, the starting assumption is kD = kS = 1.  This gives overall 
theory of acute cell injury. 
n
D
D Dn n
D
n
S
S Sn n
S
dD v k D
dt S
dS v k S
dt D
  
  
 (3) 
Postulates 5 and 6 make v and k parameters equal 1. Eq. (3) then is: 
n
D
n n
D
n
S
n n
S
dD D
dt S
dS S
dt D
  
  
 (4) 
Eq. (4) gives nonlinear dynamics of D and S network of influences and describes 
time progression of acute cell injury.   
13 
 
1.3.3 D and S are exponentially driven by I and –I, respectively 
Eq. (4) is not the final theory because injury intensity, I, is not included. When 
acute injury occurs there is an injury mechanism that can have variable amount or 
intensity.  This may be a force for trauma, concentration for poison, or duration of 
ischemia. The amount, or intensity, of acute injury mechanism is parameter, I.  
It makes sense that bigger I will give greater D. If the acute injury is stronger, 
there will be more damage in the cell. Therefore, I is proportional to D.  But what about 
S? S, cell protection, will increase as I increase, except because most of the pathways 
of S are involving enzymes, we suggest that they will saturate at some amount of I. S is 
to be considered similarly as how glucose enters urine due to the saturation of glucose 
transporters, in diabetes. We define that S saturate with damage, D. After saturation of 
S, I increase, but S would decrease because excess D would destroy S, as with 
example of ROS damaging peroxidase from above. For S, as I increase, first S 
increases but then decreases.  
We cannot change D and S by I because D and S change by time, t, in Eq. (4). 
The theory makes threshold parameters change by I: 
I
D
I
S
e
e
 
   (5) 
There are two reasons to assume an exponential function: (1) exponential 
phenomenon is ubiquitous in nature, and (2) the expressions in Eq. (5) fit how D and S 
change with I explained above. However, there is one problem. When I = 0, Eq. (5) = 1, 
to mean D and S exist when injury intensity, I, is zero. The correction is to also multiply 
Eq. (5) by I: 
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I
D
I
S
Ie
Ie
 
   (6) 
Therefore, to make proportions to equality, we add constants of proportionality to 
give Eq. (7) 
D
S
I
D D
I
S S
c Ie
c Ie


 
   (7) 
The new parameters cD and cS are multiplying constants.  The D and S are 
exponential constants like decay constants.  The general form of Eq. (7) is illustrated by 
Figure 2.  This graph depicted the value of D increase will always corresponds with I 
but that S first increase, then decrease with I increase.  Eq. (7) is the main assumption 
of acute cell injury theory that thresholds of D and S change with injury intensity I.  
The final theory of acute cell injury is attained when Eq. (7) is applied into Eq. (4) 
to give: 
( )
( )
( )
( )
D
D
S
S
I n
D
I n n
D
I n
S
I n n
S
c IedD D
dt c Ie S
c IedS S
dt c Ie D






 
 
 (8) 
Figure 2: Plots of Eq. (7). D (red) and S 
(green). Parameters are: cD = 0.1, cS = 20, D 
= 0.1, S = 0.9. 
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1.3.4 Decay from the attractor state, (D*, S*), is a function of |D* -S*| 
The last postulate is complicated in explanation, coming from the study of 
answers to Eq. (8).  Eq. (8) gives time courses that end at final points of D and S called 
“attractor states”.  Attractors are written (D*, S*).  At attractors, D and S rate of change 
equals zero. The system is “frozen” forever at (D*, S*).  
In real biological acute injury, when the cell does not have the injury before 
applying an acute injury, then D = S = 0.  Once system is injured, D and S both 
increase, but then two cases only are possible.  First case, cell may recover from injury, 
which is to heal.  Then the system is back to the uninjured state where D = S = 0.  
Alternatively, second case, where injury may be very intense (I is high) that force cells 
to die. In this case, also, D = S = 0 because cell dies and has no variables.  In real injury 
the cell begins and ends at D = S = 0, whether lives or dies. But answers to Eq. (8) 
always end at values (D *, S*) and these can be any number but not zero. 
A “bandage” was utilized to Eq. (8) to fit actual biological injury and is postulate 4.  
Instead of cell ending at (D*, S*) and staying forever at this point, postulate 4 makes cell 
at (D*, S*) for only one instant then begins to decay back to D = S = 0, or point (0, 0).  
Postulate 4 states decay is exponential from (D*, S*) to (0, 0) and how fast, the rate, cell 
goes is determined by the value of D* -S* not including sign, is absolute value |D* -S*|. 
Below is the equation: 
| * * |
| * * |
dD D S D
dt
dS D S S
dt
  
  
 (9) 
Figure 3 shows final theory where two different ODE systems, Eqs. (8) and (9) 
are “glued” together. From Figure 3, there are two critical points to mention. One, why 
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use |D* -S* | to determine rate from attractor to (0,0)?  Two, “gluing” two ODE systems 
is artificial “bandage” in theory, but it is crucial for the outcome of proposed 
experiments, which will be more reasonable after discussing why |D* -S* |? 
 
Figure 3: Theory of acute cell injury is two ODE systems called “uphill” and 
“downhill”. 
 
We call the answer to Eq. (8) “uphill” because cell goes from (D, S) = (0, 0) to (D, 
S) = (D*, S*).  “Uphill” is an analogy for kicking ball up a hill that goes to a maximum 
point before rolling back down the hill105.  This is a valuable lesson by saying Eq. (8) 
gives maximum deviation of injured system from the control state.  This is very crucial to 
understand by saying any injury, intensity of I, will cause a maximum deviation away 
from control state. However, the cell then must either recover or die. 
When thinking about meaning of D* and S*, one of these is the maximum away 
from control. If D* > S*, then D* is maximum D, and the cell will die.  However, when S* 
> D*, S* is maximum S away from control and stress responses can eliminate damage.  
Values of D* and S* tell if cell lives or dies by D* >*S cell dies, S* > D* cell lives.  This is 
the most important, as from attractor answer to Eq. (8) we can tell if cell lives or dies. 
Therefore, the cause of death is due to injury dynamics, not pathways. 
Attractor also tells how fast cell recovers or dies. If D* is very big compared to S*, 
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then lots of damage is happening in the cell. As a result, the cell will die fast. If S* is 
very big compared to D*, which means stress responses is hugely greater than the total 
damage, the cell recovers fast. But if D* is only slightly bigger than S*, then it takes long 
time for them to “battle” before D wins. Also, when S* slightly larger than D* it takes 
longer for S to win over D.  Subtracting D* and S* to get |D* -S* | tells how fast or slow 
“downhill” time course goes.  
This is a very important understanding from Eq. (8) plus Eq. (9) because in 
ischemia there is necrosis as well as DND.  In spite of much searching, no “definitive” 
pathway explanation for DND has been discovered.  The theory of cell injury defines 
why there is DND, because D* only slightly larger than S* at maximum deviation from 
the control state.  This is a prediction of the theory that it is very important to explain that 
DND is not a result from a molecular pathway or cascade, but is an outcome of injury 
dynamics. It also is a specific prediction to test the theory. 
An artificial gluing of two ODE systems infers another two important ideas about 
understanding the theory of acute cell injury. Most important for this Dissertation, we 
wonder if we can make ODE equations that start at (0, 0) and also end at (0, 0) without 
artificial “gluing” of two different ODE systems. In Chapter 4 we return to this question 
and show a new form of the acute cell injury model that does not require artificially 
gluing two ODE systems together.  
1.3.5 Neuroprotection and nonlinear theory of acute cell injury 
Here I discuss how theory gives new understanding of neuroprotection.  As 
described above, ODE system gives time courses as answers. However, there is more 
common answer to ODE systems which is called phase plane that contains all 
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trajectories for a set of input parameters (I, cD, D, cS, S, n).  It is discovered that all 
trajectories end at same point of phase plane, called attractor state.  If parameters 
change, so does attractor points.  If one parameter is caused to vary, then a series of 
phase planes is used to construct a bifurcation diagram.  The bifurcation diagram plots 
attractor point values versus the changing parameter, called control parameter.  The 
bifurcation diagram gives more general study of ODE system than single trajectories. 
The control parameter to vary in the theory is injury intensity, I.  Other 
parameters, (cD, cS, D, S, n) are set to be constant and I is changed over range Imin to 
Imax.  This is to use theory to explain, for example, 1 min ischemia, 2 min ischemia, up 
to 20 min.  Changing I is applying different strengths of injury intensity to system. 
Parameters (cD, D) are symbols for the damage agent, such as ischemia, trauma, 
poison, etc. Parameters (cS, S) are to indicate the cell type that is injured.  
In the 2012 paper, DeGracia et al show (1) there are only two types of phase 
planes, and (2) there are only four types of bifurcation curves.  The two types of phase 
planes are called monostable, when there is one attractor, and bistable, when there are 
two attractors and one repeller, shown in Figure 4. The four types of bifurcation 
diagrams are labeled as (1) monostable, (2) type A bistable, (3) type B bistable, and (4) 
double bistable.  
Figure 4 depicts on how to make a type A bistable bifurcation diagram from 
series of phase planes by changing the parameter I.  It is seen for I = 1 and 2, phase 
plane is monostable with attractor S* > D* so cell survives. At I = 4.5 and 5, is also 
monostable but D* > S* and cell dies. For I = 3 and 3.9, phase plane has two attractors 
and one repeller (blue point). It is called “bifurcation” from I = 2 to I = 3, and bifurcation 
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again from I = 3.9 to I =4.5. Bifurcation is when attractor goes from monostable to 
bistable or bistable to monostable. Taking value of D* plotted vs. I gives graph in Figure 
4B, is bifurcation diagram of D* vs I. Area marked with gray is a bistable region of ODE 
answer. Bistable answers give new explanation of therapy as now explained. 
The theory proposed a new paradigm of neuroprotection.  First, we can say 
precisely that a cell will die when D* > S*.  However, illustrated in Figure 4, when 
system is bistable, some values of I with D* > S* have the possibility to survive (in gray 
region).  Bistability is the new paradigm of neuroprotection.  A cell fated to die can only 
be caused to survive if it is in bistable region.  We now express this precisely using 
math. 
We use theory to make equation to calculate tipping point injury, IX.  When D = 
S, death and survival influences exactly equal and this is tipping point, IX. We solve this 
equation for I. 
SD II
D Sc Ie c Ie
   
To get IX tipping point value of I.  
ln lnS D
x
D S
c cI  
   (10) 
For above example in Figure 4, IX is calculated by parameters listed at bottom of 
Figure 4B. 
ln(2.5) ln(0.1) 3.22
0.1 0.9x
I    
For I < 3.22, cell survives injury because S* > D*. For I > 3.22, cell dies because 
D* > S*.  But because bistable attractors, is not so simple.  From I =3.22 to ~I = 4, 
system is bistable and could either live or die because both D* > S* and S* > D* 
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attractor is answer to ODE system.  This means system injured by I values from 3.22 to 
~4 could possibly live.  These ODE answers indicate that therapy is only possible when 
injured system is bistable. For I > ~4, there is only attractor with D* >S*, and cell will die 
always because no survival attractor is in ODE answer.  
Figure 4: Bifurcation 
diagram made from series 
of phase planes varying 
parameter I. Figure from 92 
 
 
 
 
 
 
 
 
We think this is the most important conclusion from the theory that therapy is only 
possible when injury is bistable in dynamics. This is the most important prediction of 
theory. We would like to prove if this prediction is true or not. But to prove this 
prediction, we must measure D and S time courses. Therefore, the purpose of My 
Dissertation is to test whether it is possible to measure D and S time courses. 
1.4 Hypotheses and Aims 
As mentioned above, the nonlinear dynamic theory of acute cell injury proposed 
new understandings. First, if D* > S* after an injury, the injured cell will die. The theory 
tells us the cell dies not because of some specific set of molecular pathways, but 
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because of injury dynamics. Second is the prediction that therapy is only possible when 
there are bistable dynamics.  These important predictions of theory need to be tested by 
measuring the theory. The key measurements are to measure how total damage, D, 
and total stress response, S, change in time. However, D and S are new ideas to this 
theory and never previously measured. This Dissertation will test if it is possible to 
measure D and S by proposing the three Aims of this Dissertation. 
Aim 1: D can be quantitatively estimated by levels of protein aggregates 
Hypothesis: As described previously, several damages happened in neurons 
after brain I/R, including free radicals, acidosis, ions concentration changes, an 
alteration in redox reaction, proteolysis, amongst others.  In the theory, D is the total of 
all damages to the cell. Many of these damages result in denaturation of proteins.  The 
laboratory of Dr. Bingren Hu reported an accumulation of protein aggregates (PA) in 
neurons after brain I/R106, 107. PAs are denatured proteins coated with ubiquitin. PAs are 
found inside neurons after brain I/R and in hippocampal CA1 persist until death by 
DND106, 108, 109.  PAs also form in neurons that survive, like hippocampal CA3 brain 
region, but then disappear at long reperfusion time, and CA3 survives108.  I hypothesize 
that PAs can be a marker of how D changes in time because many damage pathways 
converge to cause proteins to denature after brain I/R. I will measure PAs changing in 
time by Western blot for ubiquitinated proteins and quantify with densitometry.  
Aim 2: S can be estimated by changes in mRNAs on ribosomes 
Hypothesis: It is assumed that the target of changes in genes is to protect the 
cell. Then, the gene changes may allow us to track or estimate the variable S.  
However; it is also known that when mRNA changes, the protein is not always 
22 
 
translated. When mRNA is on ribosomes, it is more likely to be translated than when not 
on ribosome. Therefore, it is hypothesized that mRNA on ribosomes is one way to 
estimate S.  I will measure mRNA on ribosomes by isolating ribosomes, extracting 
mRNA and using microarrays to measure mRNAs. I will then compare the result by also 
isolating the total mRNA. 
For both Aim 1 and Aim 2, I will measure time courses in hippocampal brain 
region CA1 that dies and CA3 that survives after brain I/R, as given in the next chapter. 
Aim 3: D and S measured time courses fit theory time courses 
Hypothesis: How do we know the measurements above are a good way to 
estimate D and S change in time? The Aims 1 and 2 will measure time courses. The 
time courses should be fit to the D and S time courses generated by the theory of acute 
cell injury. The measured time courses of D and S are to be fit to the ODE time courses 
using the Nelder-Mead simplex method. Nelder-Mead is a way to fit nonlinear data to 
ODE time courses, used in engineering and physics110. Two parts to this Aim 3 are 
necessary. First, to learn how to fit all measured data to ODEs because the theory is 
new. There are many parameters in Eq. (8). It is to be studied which are the best 
parameters to make sense of brain I/R. Second, there may be the case the measured D 
and S time courses do not fit Eq. (8). Then it is to ask: can Eq. (8) be modified so it will 
give the better fit to measured time courses? This is the method of physics to have 
equations, then collect data and if needed to modify equations to provide a better fit of 
data. 
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CHAPTER 2 - PROTEIN AGGREGATES AS ESTIMATORS OF D 
2.1 Introduction 
Based on the theory developed by DeGracia et al (2012)92, an acute injury of 
intensity, I, damages the cell but also activated genetic stress responses. Total damage, 
D, and total stress responses, S, change with time based on a mutual inhibition given by 
the theory equations.  This is a “winner take all” model where if D dominates, the 
system dies, and if S dominates, the system survives.  
Since D is total damage, a possible measure of D is protein aggregates (PA). 
PAs are damaged, denatured, or misfolded intracellular proteins in neurons caused by 
ischemia (Liu et al., 2005). Many changes in brain I/R could be made to denature 
proteins. Proteins need proper pH and ions and redox to maintain correct folded state. 
Proteins also need chaperones to fold correctly and chaperones need ATP.  Brain I/R 
causes loss of ATP, acidosis, changed ion conditions, and changes in oxidation-
reduction of the cell. The PAs could be good measure of D because many separate 
damage pathways cause together the final PAs. This is why it is proposed to measure 
PA to estimate D. 
We hypothesized that D could be estimated by measuring the change of PAs 
over time in an animal model of global brain ischemia, which mimics brain damage after 
cardiac arrest and resuscitation.  Damaged proteins are covalently linked many times 
on their surface to the small peptide ubiquitin to mark them as damaged and send them 
for elimination to the proteosome. The ubiquitination of the PAs provides the means to 
identify them.  Figure 5 is data from previous experiment in Dr. DeGracia’s lab showing 
PAs detected by Western blot. This data shows PAs smear from 100-200 kDa on SDS-
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PAGE after ubiquitin Western 
blot. Samples are NIC, 24R and 
48R after 10 min ischemia for 
CA1 and CA3. Four dissections 
were pooled for each lane. Only 
one replicate is there for each 
experimental group. In Figure 5B 
is shown density of 100-200 kDa 
smears. It is seen PAs increase 
at 24R and 48R in CA1, but 
increase and decrease in CA3. My work will reproduce the similar method as explained 
below. 
For this Aim 1, PAs were measured by Western blot for ubiquitinated proteins 
and carefully quantified by densitometry. This project’s goal was to obtain the most 
reliable quantification of PAs as a function of time from microdissected hippocampal 
CA1 and CA3 after 10 min global brain ischemia. CA1 dies and CA3 survives the 
ischemia, therefore the D estimate in CA1 is expected to exceed CA3.  
2.2 Overall Design of Aim 1 Experiments 
Figure 7 illustrates the overall design for Aim 1. Experimental groups are  
1. nonischemic controls (NIC) 
2. 10 min ischemia and 30 min reperfusion (30mR) 
3. 10 min ischemia and 8 hr reperfusion (8R) 
4. 10 min ischemia and 16 hr reperfusion (16R) 
Figure 5: Western blot for ubiquinated smear to
show PAs in CA1 and CA3. 
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5. 10 min ischemia and 24 hr reperfusion (24R) 
6. 10 min ischemia and 48 hr reperfusion (48R) 
7. 10 min ischemia and 72 hr reperfusion (72R) 
Because of the need to pool samples as shown above in Figure 5, and to give 
enough material to ensure at least 3 lanes of PAs per experimental group, there will be 
15 animals per each experimental group to be pooled as described below.  The time 
course was chosen to be 72 hr because CA1 dies in 72 hrs after 10 min global ischemia 
(Figure 6). The other time points are based on the extensive knowledge of global 
ischemia.  It is known that CA3 has returned to normal by many measures by 24 – 36 hr 
reperfusion.  So three time points (30mR, 8R, and 16R) sample when both CA1 and 
CA3 show evidence of damage, and after CA3 has recovered (24R, 48R and 72R). 
 
Figure 6: 10 min global brain ischemia kills CA1 but not CA3. 
The general design is shown in Figure 7 (using NIC to illustrate the work flow). 
CA1 and CA3 were dissected bilaterally then homogenized, then centrifuged to give the 
heavy, low speed pellet containing PAs106.  This fraction was further processed as 
described below to give a fraction that was treated in a high salt and detergent solution.  
Whatever was insoluble in this solution was by definition a PA.  A PA pellet was 
obtained from centrifugation, run on SDS-PAGE, then Western blotted using anti-
ubiquitin antisera. The film exposures were carefully quantified as described below to 
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give PA levels at each time point in CA1 and CA3. The plots of PA levels versus time 
were then taken as the estimates of D as a function of time in CA1 and CA3. 
 
Figure 7: Procedure to isolate protein aggregates to estimate D, total damage 
2.2 Materials and Methods 
Materials: Ubiquitin Conjugating Kit was from Enzo Life Sciences (Farmingdale, 
NY). Mouse anti-ubiquitinated protein antisera was from Cell Signaling Technology 
(Danvers, MA). Nuclear and Cytoplasmic Extraction Reagents kit was from Thermo-
Fisher (Waltham, MA). Amersham ECL Western Blotting Detection Reagent was from 
GE Healthcare Life Sciences (Pittsburgh, PA). Secondary antisera and sheep serum 
were from Sigma-Aldrich (St. Louis, MO). All other chemicals were molecular biology 
grade. 
Ischemia Rat Model: Long Evan male rats weighing 300-325 gram were subject 
NIC(15)
pool samples
dissect regions
Estimate D Experimental Protocol
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anti‐ubiquitin Western blot,
densitometry
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to 10 minutes of global brain ischemia and various durations of reperfusion. A total of 
123 animals in the experimental groups shown above were used. Animal experiments 
were approved by the Wayne State University Animal Investigation Committee and 
were performed in accordance with the Guide for the Care and Use of Laboratory 
Animals (National Research Council, revised 1996). In order to induce global brain 
ischemia, we performed the bilateral carotid artery (two-vessel) occlusion and 
hypovolemic hypotension (2VO/HT) surgery model as previously described by Smith et 
al20,69,75,114. Nonischemic controls (NIC) were given sham surgery but no ischemia. All 
animals were maintained normothermic at 37oC during ischemia and for the first 1 hour 
of reperfusion. Temperature control is important because even a slightly lower of body 
temperature can prevent cell death. Each of experimental groups consists of at least 15 
animals (n=15). Experimental groups were given above. 
The rats were induced with 5% halothane anesthetic agent prior the starting of 
the surgery. The dose was maintained at 2% halothane plus 100% O2 during the 
surgery through a nosecone. Core body temperature was maintained at a constant level 
at 37 ± 0.5° C with a homeostatic blanket system for ischemia period and then 1 hour of 
reperfusion. The temperature was measured by a rectal temperature probe. A 
thermistor was applied in a temporalis muscle to maintain head temperature at a 
constant level approximately 37 + 1° C by using heat lamp.  A catheter connected to a 
blood pressure machine was inserted to the tail artery to monitor mean arterial pressure 
(MAP) during the surgery.  A neck incision was carefully made to access both of the 
common carotid arteries and the vagus nerve was avoided to disturb. Another incision 
was made in the inguinal are to access and insert a catheter to the femoral artery. This 
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femoral artery was used to withdrawal blood in order to cause hypovolemia.  After 
succeeding the insertion process of the catheter to the vessel, ischemia was induced by 
the withdrawal of ten ml of blood until the MAP is reduced to 50 mmHg. Then both of 
the carotid arteries were clamped by using micro-aneurysm clips to induce global 
ischemia which was applied for 10 minutes. At the end of 10 min, the blood was 
reintroduced to the femoral artery at 5 ml/min.  Next, all the vascular access points were 
sutured.  The temperature of 37 °C and full anesthesia were kept constant for 1 hour of 
reperfusion.  Rats were kept at a 12 hour light/dark cycle in post-operative period. Rats 
were provided access to water and food freely during the reperfusion time after return to 
cage.  Some post-operative exclusion criteria were applied. If rats lost more than 15% of 
starting body weight for one day or showed seizures, they were excluded. The survival 
rate for all reperfusion groups was 75-80%.   
Microdissection of brain regions: After skull opening, brains were carefully 
pulled using a Rongeur rinsed in DEPC-H20. Next the brain was snap frozen for ten 
seconds in the ethanol bath containing dry-ice to prevent the softening and breakdown 
of the brain tissue.   Then the brain was positioned carefully in the brain blocker (Kopf 
Instruments, Tujunga, CA, USA) to expose the hippocampal region. Coronal slices were 
taken at posterior to Bregma in the coordinates from -2.44 mm to -4.78 mm115 , then 
immediately snap frozen in dry ice-ethanol bath, to maintain a semi-frozen brain slices.  
The brain was placed under dissecting microscope which pre- zapped with RNase 
wipes and cooled by a small piece of dry ice to obtain a hippocampal CA1 and CA3 
dissection.  
To obtain CA3, a vertical cut was made bilaterally, medial to the curve of CA3 
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border. Then, the CA3 region was cleaned by peeling the surrounding cortex. Next, to 
obtain a CA1, a cut was made horizontally above the dentate gyrus, marked by a line 
configuration of a continuous, cross-sectional blood vessels. Hippocampal CA1 brain 
region is located superior from this blood vessels. Next, cerebral cortex was removed 
from the piece at corpus callosum to give a final CA1 section. These procedures were 
applied to both hippocampal region bilaterally.  CA1 and CA3 pieces of tissue were 
placed individually in a pre-weighed RNase-free Eppendorf tubes and weighted 
immediately. After weighing procedure, all samples in Eppendorf tubes were frozen in 
dry-ice ethanol bath and then kept at -80o C freezer until the next experiments. An 
average of 15-20 mg wet weight tissue was collected for each individual CA1 and CA3 
in one rat. Cerebral cortex was also dissected by slicing forebrain from -2.44 mm 
posterior to Bregma to the front of brain using the brain blocker as a marker. The tissue 
is also frozen in RNase free Eppendorf using ethanol dry-ice bath and kept at -80 °C for 
further usage. 
HSP70 validation of ischemia surgery:  For each experimental group, a control 
was performed to determine the quality of the ischemia surgery. The forebrain was 
thawed, 100 mg cerebral cortical gray matter was shaved from the frontoparietal lobes, 
immediately homogenized at 1:10 (w/v) in ice-cold buffer of 50 mM HEPES, pH 7.4, 150 
mM NaCl, 1 mM EDTA, 25 mM DTT, 1% (v/v) Triton X-100, 10% (v/v) glycerol, 5.2 μl/ml 
protease inhibitor cocktail (Sigma). This unfractionated homogenates was centrifuged to 
give the post-mitochondrial supernatant (PMS). After Lowry assay to determine protein 
concentrations, each experimental rat was run at 125 micrograms protein in a lane on 
SDS-PAGE gels and then Western blotted for HSP70 protein57.  After boiling for 90 sec 
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in 2x Laemmli buffer, 125 μg of each rat cerebral cortex PMS was run on 10% SDS-
PAGE gels at 25 mA/gel at constant current. The gel was transferred to nitrocellulose 
using constant current at 100 Ma, overnight. The primary anti-HSP70 was incubated 1 
hour at 1:1000 dilution at room temperature and the secondary antibody at 1:15000 was 
at room temperature for 45 min. The main buffer was Tris buffered saline with 2% 
Tween-20 (TTBS), and 7-4-4 min washes between all steps using TTBS. Membrane 
was blocked with 5 % low-fat milk in TTBS prior to the primary antibody. Any samples 
that did not contain HSP70 in cerebral cortex were excluded. 
 HSP70 is a stress response protein not present in control rats, but is produced in 
high quantities after brain ischemia. HSP70 indicates successful ischemia in a rat. 
Those rats displaying HSP70 signal were kept and those not displaying it were 
eliminated from the study. On average, 85% of the rats in the reperfusion groups 
showed HSP70 signal (Table 1). HSP70 was detected in cerebral cortex to prove 
ischemia occurred during surgery. Figure 8 shows representatives cortical HSP70 of 
samples for 8R group. Every sample was tested for HSP70 in cerebral cortex before 
further processing. All of HSP70 data for both D and S estimation are shown in 
Appendix B. 
 
Figure 8: HSP 70 in 8R samples chose for further processing. 
 
The HSP70 was only used to validate the surgeries. We could not use it to satisfy 
the Aims of this Dissertation because: (1) HSP70 is a single pathway and the nature of 
D requires a marker that derives from multiple upstream pathways, such as PAs, (2) 
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cerebral cortex is heterogeneous in cell types, containing dozens of types of pyramidal 
neurons and interneurons, as well as glia and blood vessels whereas CA1 and CA3 in 
contrast are ~90% the same cell type, the respective pyramidal neurons, and (3) the 
cerebral cortical cells producing HSP70 change over time, being neurons early on, then 
blood vessels and glia also produce HSP70 at later reperfusion121.  Hippocampus was 
more suitable to test the Aims than cerebral cortex. However, there was not enough 
material to directly test HSP70 in the hippocampal dissections and cortex was used 
fortuitously to serve this purpose. Given this purpose, we did not quantify the HSP70 but 
instead treated it as a binary outcome: it was either present or absent, and if absent 
from a reperfused animal, that animal was excluded from the study.  
An average of 85% of reperfused rats produced cortical HSP70. From all 
experimental samples prepared for PA isolation, the break down by group of HSP70 
antibody detection is shown in Table 1. 
Table 1: Percent samples showing HSP70 per group 
NIC 30mR 8R 16R 24R 48R 72R 
n HSP70 na 15 16 12 15 16 16 
n total na 15 18 19 18 18 19 
percent na 100.0% 88.9% 63.2% 83.3% 88.9% 84.2% 
 
Treatment of Pooled CA1 and CA3 for Protein Aggregates: Below is the 
general protocol for isolating PA to estimate D as depicted above in Figure 7.  Of the 
rats with HSP70, the corresponding CA1 and CA3 microdissections were randomly 
pooled within each experimental group to give a total of 50 mg wet weight which is 
required to extract enough PAs to be able to detect by Western blot (as was determined 
by prior pilot experiments).  
The pooled CA1 and CA3 tissues were homogenized in Cytoplasmic Extraction 
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Reagent I (CER I). Samples were then centrifuged for 10 minutes at 16,000 rpm and 
4oC. The pellet fraction was taken for further processing because the PAs run in the 
dense fractions of the cell108. The pellet fraction p1 was subject to the nuclear isolation 
and lysis kit using the Nuclear and Cytoplasmic Extraction Reagents following the 
manufacturer’s instructions. Pellet p1 was vortexed for 15 seconds, and incubated on 
ice for 10 minutes. Cytoplasmic Extraction Reagent II (CER II) was added, then sample 
was vortexed for 5 seconds, incubated on ice for 1 minute, and vortexed again for 5 
seconds. Sample was then centrifuged for 5 minutes at 16,000 rpm and stored at -80oC 
overnight. Then, p1 pellets were thawed, suspended in Nuclear Extraction Reagent 
(NER), vortexed for 15 seconds, and then incubated on ice for four periods of 10 
minutes, vortexed for 15 seconds after each period. Pellet samples were then 
centrifuged at 16,000 rpm for 10 min at 4oC. The resulting pellet, p2, was used as input 
for the PA isolation procedure. 
PAs were isolated by the method of Liu et al (2005)108. Pellet p2 was dissolved in 
a solution containing 2% Triton X-100 and 400 mM KCl and rocked on a rotator for 30 
min at 4oC. This solution dissolves all but the most insoluble substances. PAs are 
defined at those substances which cannot be dissolved in this solution. After rocking, 
the samples were centrifuged at 10,000 rpm for 10 min at room temperature. The 
resulting pellet, p3, was the PA fraction. Pellet p3 was dissolved in 25 L of 1X 
homogenization buffer. Two microliter aliquots were taken for Lowry protein 
determination. The remainder was mixed with equal volume 2X SDS-PAGE loading 
buffer, vortexed vigorously to facilitate dissolving, and then boiled for 2 minutes. 
In Vitro Ubiquinated Protein Reaction: To provide a sample that we knew 
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would be constant from gel to gel, we ran an in vitro reaction to make PAs in the test 
tube using a HeLa lysate fraction enriched in the ubiquitination enzymes (“control PA”), 
following the kit manufactures instructions. Enough control PAs were prepared to run at 
least 20 lanes total.  
SDS-PAGE and Western Blot: SDS-PAGE gels were 10% running gel and 4% 
stacking gel. Fifty micrograms of each sample were loaded per lane. Each gel also 
contained a lane for molecular weight markers and two lanes of control PAs, using 3 
and 1.5 microliters of control PA solution. Experimental groups were partitioned among 
the gels so that those with less PAs would be on the same gel and those with greater 
PAs would be on the same gels, to facilitate equalizing film exposure times after 
Western blotting and to avoid large differences in PA signals that would complicate film 
exposures. Gels were run at a 25mA/gel constant current for 6 hr.  Gels were then 
equilibrated in electroblot transfer buffer for 15 minutes before electroblotting at 100 mA 
constant current overnight for 16 hrs. After, nitrocellulose membranes were fixed in 25% 
isopropyl alcohol and 14% glacial acetic acid for 15 min at room temperature then 
rinsed 10 times in distilled H2O and stored at 4oC until used. 
For Western blotting, membranes were blocked 5% low fat milk in TTBS and 
rocked for 45 minutes at room temperature. Primary anti-ubiquitin antisera were applied 
at 1:1000 overnight at 4oC with rocking. Secondary antisera was applied at 1:15,000 for 
45 min at room temperature. Between all treatments, membranes received three quick 
rinses with TTBS and seven, four, and four minutes TTBS washes. After final washes, 
ECL reagent was applied to initiate light emission. Multiple exposure times were taken 
to determine the optimal exposure time for each membrane. At least three exposures of 
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each membrane ranged from ~ 1 to 5 minutes each.  
Gels Run: There were three gel runs to ensure proper quantification of the main 
dataset of CA1 and CA3 samples. (1) A pilot gel was run with 1 sample from each 
experimental group to determine the relative intensities of the PAs to determine how to 
set up the main gels containing all samples. (2) The main set of six gels ran the pooled 
CA1 and CA3 experimental groups. (3) A final gel was run with 1 sample from each of 
the six main data gels, along with the 1.5 L control PAs to determine the ratio of 
sample to control PA as a check on the main gel set.  
Data Analysis: All films were analyzed by scanning densitometry. 24-bit scans 
of each film exposure were obtained on a flatbed scanner (Microtek, ScanMaker 
9800XL) and converted to 8-bit in Photoshop (ver. 8). NIH ImageJ software (Version 
1.51p, 2017) was used to study each exposure for over- and under-development. 
GelAnalyzer2 (GA2) was used to determine lane densities on optimally exposed films. 
GA2 was preferable to ImageJ because it allowed better background correction and 
provided volumetric density analysis of the lanes. In contrast ImageJ only provided the 
area under the curve of a line drawn from the top to bottom length of a lane. Final data 
were expressed as averages +/- 2 sigma (2, 95% confidence intervals). 
2.3 Results 
The main data set of PA Westerns, including all exposures, is shown in Figures 
9-14.  The optimal exposure of each of the six Western blots was determined. Figure 15 
(left) is example of one exposure sets for one membrane from the main data set. Figure 
15 (right) shows line scan densitometry for those exposures that makes a series of 
peaks and valleys.  The decision to choose one exposure as optimal required maximum 
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peak heights plus maximum peak-to-peak height. If under exposed, the peaks would be 
less than maximum. If over exposed, the peak-to-peak height decreased.  For example 
of Figure 10, the orange curve, exposure B was found to be the optimum exposure. 
Figure 16 shows the line densities for all six exposure sets.  
  
Figure 9: PA Data Gel 1 exposures 
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Figure 10: PA Data Gel 2 exposures 
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Figure 11: PA Data Gel 3 exposures 
 
  
38 
 
 
Figure 12: PA Data Gel 4 exposures 
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Figure 13: PA Data Gel 5 exposures 
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Figure 14: PA Data Gel 6 exposures 
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Figure 15: Densitometry of exposure sets Left. Three exposures of same membrane 
containing 8R, 16R, and 24R CA3 PA samples. Right. Line density scans performed in 
ImageJ for the corresponding exposures.  
 
 
Figure 16: Image J analysis of the exposure sets of each of the six main data gels.  
 
After determining the optimal exposure, we needed to quantify the densities so 
we could compare densities from blot to blot since there were too many samples to run 
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on a single gel.  The control PA lanes was intended for this use. The PA control lanes 
was to provide a normalizer, a denominator, for each of the sample lanes, allowing us to 
compare lanes from gel to gel.  
To check if this was correct, we added two lanes of PA control to each gel, one 
with twice the amount than the other.  There should have been a 2-fold difference 
between the PA control lanes.  However, the optimal exposures as determined by 
ImageJ analysis showed that in some cases, there was not a 2-fold difference between 
the control PA lanes (Table 2).  Therefore, we could not simply divide the sample 
densities by the control PA densities to compare across all six data gels.  
Table 2: Densitometric ratio of PA control lanes for optimal exposures.  
gel1D gel2B gel3B gel4D gel5D gel6C 
1.6 1.9 1.6 2.4 1.8 3.1 
Should be 2. 
We therefore did a second strategy to normalize the main data gels. We ran a gel 
that contained one sample from each of the six main data gels as well as the PA control 
lane (Figure 17).  As above, multiple exposures were taken and the optimal exposure 
determined. From this exposure the ratio of 1.5 L control PA to the sample was taken 
and then compared to the same ratio on the corresponding gel from the main data set. If 
the densities were the same, the ratio of the ratios should be equal to 1. As seen in 
Table 3 “main/test” column, most of the samples were close to 1, but ranged from 0.62 
to 1.14. Therefore, to normalize the density of the six main data Westerns, the density 
from each optimal exposure was multiplied by the value in the main/text column. This 
then normalized all six blots of the main data set to the same basis. 
Together, the steps above constituted our best efforts to ensure adequate 
quantification of the PA density of the main data gels. To summarize: (1) the optimal 
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exposure of each blot was determined, and (2) the ratio of PA control to sample was 
corrected based on the test gel (Figure 17) that independently measured the ratio of a 
specific sample on one of the test gels to the PA control.  
 
Figure 17: Ratio of control PA (cPA) to sample. One or more samples from each 
main data gel was run on this test gel along with the control PA to check the ratio of that 
sample to the PA control.  The variance between the control PA/sample ratio was 
corrected as per Table 3, main/test column. 
 
Rescaling of Data: At this stage, the data, although normalized and comparable 
across all 6 blots, was still in arbitrary volumetric density units. Therefore, to finalize the 
data analysis the following steps were performed: (1) each sample density (corrected as 
described above) was divided by the 1.5 microliter control PA density, (2) the groups 
were averaged and standard deviation calculated, (3) the NIC average was taken as 
baseline zero and subtracted from the average of each reperfused group, (4) Finally, 
the data was rescaled to 1.0 by taking the largest average density in either CA1 or CA3 
as the denominator for all samples. The largest average value that divided all the other 
CA1 and CA3 values was from CA1 at 48R. 
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Table 3: Ratio of control PA (cPA) to sample.  
 
 
 
 
 
 
 
 
 
 
 
(Test column) for gel in Figure 11, 
compared to the same ratio from main 
data set (main). Main/test is ratio of the 
ratios and was used to correct the main 
data set densities to ensure the densities 
across all six gels were on the same 
basis. 
 
Calculation of variances: Standard deviations were expressed as 95% 
confidence interval using the formula: 
ܺ േ ܼ	 ܵ√ሺ݊ሻ (11) 
X is the mean, Z is the Z-value from standard z tables, s is the standard 
deviation, n is the number of samples. 
The final data is shown plotted as rescaled averages + 95% CI in Figure 18, 
where this is to be taken as the estimate of D in the nonlinear dynamical theory of cell 
injury. As seen here and in Figure 11, the PA density, which is our D estimate, is 
significantly greater in CA1 than in CA3 at the 95% confidence level. 
45 
 
 
Figure 18: Final plot of PA data to estimate D with respect to time. 
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CHAPTER 3 - POLYSOME MRNA CHANGES AS ESTIMATORS OF S 
3.1 Introduction 
As previously described in Chapter 1, many new mRNAs made during brain I/R 
come from stress responses like heat shock, UPR, anti-oxidant response, NFkB, DNA 
repair genes and others. These genes make proteins to protect the cell. For example, 
HSP70 protein helps refold denatured proteins by binding to exposed interior sites and 
allowing the target protein to achieve its native conformation. But, also stated above, if 
mRNA increases, it will not always be translated to protein. One example is an egg cell 
that makes many mRNAs that are not translated until fertilization and prior to 
fertilization, the mRNAs are bound to proteins that inhibit their translation122. However, it 
is not mRNAs, but functional proteins that remove and repair cell damage.  But we 
cannot measure every protein for every new mRNA. As a surrogate of mRNAs that are 
likely in the process of being translated, we can measure mRNA on polyribosomes. 
Estimating the total stress responses in the cell is also problematic. There are 
two categories of stress response: (1) gene independent and (2) gene dependent. Gene 
independent responses are those already present in the cell and triggered by the 
accumulation of damage. An example was given above of the taurine system that uses 
existing anion channels to normalize intracellular tonicity. Gene dependent stress 
response are those in which cell damage triggers changes in gene expression, the new 
mRNA is made (transcribed) and then translated to protein, where the new protein 
serves a role in stopping or cleaning up the damage. We assume that both gene 
dependent and independent stress responses will vary in a qualitatively similar fashion. 
That is, both will increase with injury magnitude to a point, and then decline with injury 
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magnitude (as shown in Figure 2). With this assumption, we can measure one as an 
estimate of both.  There are many gene independent responses, and it is not technically 
feasible to measure all of them. However, the total gene dependent responses can be 
measured using microarray technology. Therefore, we used microarrays to measure 
gene expression changes to estimate S, knowing this will provide a lower limit of the 
real value.  
3.2 Overview of Experimental Designs 
The design of Aim 2 was similar to Aim 1.  The same experimental groups 
described in Aim 1were repeated. The number of animals per group was determined by 
how much total and polysome RNA was isolated from a single bilateral dissection of 
CA1 or CA3.  It required pooling 5 rats to provide 80 mg wet wt. of tissue to produce 1 
g of polysome RNA to run on a microarray, as well as 1 g of total RNA. Total and 
polysome RNA was isolated 
from CA1 and CA3 of the 
same experimental groups in 
Aim 1. The overall workflow is 
illustrated in Figure 19.  
 
 
 
 
Figure 19: Estimate S 
experimental protocol. 
Procedure to isolate total and 
polysome mRNA for estimating 
S, total stress response. NIC is 
used to illustrate workflow. 
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CA1 and CA3 were microdissected and pooled as described above, then 
homogenized, centrifuged, and post-mitochondrial supernatant obtained. Twenty 
percent of PMS was suitable to obtain total RNA by TRIzol extraction. The remaining 
PMS was used to concentrate polysomes using the sucrose pad centrifugation method. 
RNA was extracted by TRIzol from the polysome pellet. Both total and polysome RNA 
were shipped to the company, Genome Explorations (Memphis, TN), who performed 
the microarrays. Genome Explorations returned to us the files containing the raw 
microarray data. In addition, Genome Explorations performed digital PCR of known 
transcripts used to spike our samples. This allowed conversion of the microarray raw 
data to copy number (CN) which is the number of mRNA transcripts per ng of RNA.   
We then performed analysis of the microarray data to determine how to use it to 
obtain a numerical estimate of S, the total stress response. The analyses performed are 
listed here and detailed descriptions given ahead: 
1. Determining the correct method of pre-processing which includes: (1) 
background subtraction, (2) probe summation, and (3) chip normalization 
to compare results across microarray chips.  
2. Three ways to calculate the multi-dimensional distance (MDD) were 
tested. MDD was the method we used to express microarray results as 
numerical estimates of S.  
3. MDDs calculated from total and polysome RNA were compared. MDDs 
from polysome RNA, but not total RNA, were consistent with the 
theoretical expectations. 
4. We performed convention bioinformatics, varying the statistical stringency, 
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on the polysome RNA microarrays to compare to MDD calculations.  
The final result, analogous to that of Aim 2, was a quantitative expression of how 
polysome mRNAs changed with time after ischemic injury, which served as the 
numerical estimate of the S time courses in CA1 and CA3.  
3.2 Materials and Methods 
Materials: TRIzol was from Thermo Fisher Scientific Inc. RNase Zap was 
purchased from Invitrogen (Carlsbad, CA). Diethylpyrocarbonate (DEPC), 
cycloheximide (CHX), donkey anti-rabbit (NA934) and all other reagent grade chemicals 
are from Sigma-Aldrich (Saint Louis, MO). HSP70 antiserum (SPA-820) was from Enzo 
Life Science (Farmingdale, NY).   
Animal surgery, microdissections, and sample pooling: Surgery were 
performed with the same method as previously described in Chapter 2, using 2VO/HT 
surgery model which induced 10 min of global brain ischemia in rats. Experimental 
groups were identical to those in Chapter 2. A total of 105 rats (15 animals x 7 groups) 
including NIC were used for Aim 2. After brain I/R surgery, hippocampal CA1 and CA3 
were dissected as previously described in Chapter 2, except all procedures were 
maintained in RNase free working condition, in order to minimize RNase contamination 
(described in more detail ahead). After microdissection, tissue was kept frozen in -80oC 
until use. Also, for each experimental group, the cerebral cortex was used to test for the 
presence of HSP70 protein as described in Chapter 2. The RNA abbreviations used 
were: CA1 polysome mRNA (CA1p), CA1 total RNA (CA1T), CA3 polysome mRNA 
(CA3p), and CA3 total RNA (CA3T).   
RNase free working conditions: The following precautions were made to 
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minimize RNase contamination114. First, all consumables and containers were 
purchased specifically as RNase-free. Second, RNase Zap (Invitrogen, Carlsbad, CA) 
was used to wipe all work bench surfaces. Then, DEPC-H2O was applied five times for 
washing the pre-RNase Zap surfaces. All solutions were made using ddH20 with 
diethylpyrocarbonate (DEPC) dilution with the ratio 1:20 and autoclaved for 20 minutes 
to inhibits RNase activity. All glassware, including the dounce homogenizers, pestles, 
and Pasteur pipettes were baked at 220 °C for at least 3 hours in a pre-heated oven, 
then cooled to room temperature before using in any procedures.  Finally, gloves and 
the face mask were necessary to wear during all procedures. All room temperature 
procedures were conducted in the laminar flow hood.  
Polysome pellets: All procedures were performed on ice and maintained 
RNase-free conditions. Polysome pellets were isolated by the method of Khandijan et 
al116. As outlined above, one replicate for polysome pellet sample was derived from 
pooling five microdissections of CA1 and CA3 brain regions, to give 80 mg wet wt. 
tissue. It was previously tested that 80 mg gives one microgram of polysome RNA input 
for microarrays. The pooled brain regions were dounce homogenized by pestle A to 
prevent rupture of the nucleus and any contamination from RNA inside the nucleus57.  
Homogenization procedure was using the ratio 1:8.5 (w/v) to 1 g tissue in ice-cold 
homogenization buffer consisting of 340 mM sucrose, 50 mM Tris, 1mM DTT, 5mM 
MgCl2, 25mM NaCl, 300mM cycloheximide (CHX), 80U/ml RNase inhibitor (Invitrogen), 
5.2 μl/ml protease inhibitor cocktail (PIC) (Sigma), pH 7.4. CHX was added to keep 
polysomes intact. The homogenates were centrifugation at 9000 x g, 15 min, 4 °C to 
provide post mitochondrial supernatant (PMS). Next, PMS was separated into two 
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tubes. For total RNA isolation, 1/5 of PMS in RNase-free Eppendorf was vortexed with 
the TRIzol addition with the ratio 1:1 and then kept at -20 °C.  The other 4/5 of PMS was 
taken to 1% final concentration of NP-40 for polysome pellet isolation procedure. An 
800 μl miniultracentrifuge tube was used to load 350 μL of PMS above the sucrose pad.  
A volume of 350 μL sucrose pad of 20% w/v sucrose, 50 mM Tris, pH 7.4, 25 mM NaCl, 
5 mM MgCl2, 300 mM CHX, 1 mM DTT, 5.2 μL/ml protease inhibitor cocktail (Sigma, St.  
Louis, MO, USA), and 80 U/ml RNase inhibitor (Invitrogen, Thermo Fisher Scientific, 
Waltham, MA, USA) was loaded before the PMS. Samples were centrifuged at 29,400 
rpm for 1.5 hr, 4 °C using the SW55 rotor. Supernatant was aspirated carefully by using 
glass Pasteur pipets and discarded. The remaining pellet was the polysome pellet. The 
pellet was resuspended with homogenization buffer by gentle aspiration mixing 
procedure. The volume of homogenization buffer added was 500 μL for polysome pellet 
and 350 ul for total RNA pellet. The polysome pellets resuspension was moved to the 
RNAse free Eppendorf tubes. Finally, TRIzol reagent at 1:1 ratio of volumes to 
homogenization buffer was added, and then the samples was stored at -20 °C until RNA 
extracted. 
RNA extraction: From the mixture of pellet resuspension with homogenization 
buffer and TRIzol that has been stored in -20oC, RNA extraction procedure was 
performed as instructed by vendor. The RNA pellet was resuspended in sterile ddH20, 
and then flowed through the RNAeasy column (Quiagen, Valencia, CA, USA) as per 
vendor instructions.  After column elution process, 1 L was taken to determine the 
A260:A280 ratio which was at least 1.7. The RNA concentration was given from UV 
absorbance.  In pilot studies, the CA1 and CA3 RNA were run into denaturing agarose 
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gel electrophoresis to confirm its quality.  Finally, the RNA prep was shipped overnight 
to Genome Explorations (Memphis, Tennessee) on dry ice.  The microarray procedures 
next will be given.   
Microarray procedures: All microarray procedures were done by Genome 
Explorations who provided us the written methods in this and the next section. Capillary 
electrophoresis procedure with RNA 6000 Nano Lab-on-a-Chip kit and the Bioanalyzer 
2100 technology (Agilent Technologies, Santa Clara, CA) were performed as per the 
manufacturer’s instruction to determine RNA integrity. Next, 5-25 ng per RNA sample 
were transformed to cDNA. This cDNA went through an amplification and fragmentation 
process, and biotin-labeled based on the manufacturer’s instructions by using the 
Ovation Pico WTA, Ovation Exon Module, and Encore Biotin Module kits (NuGEN, San 
Carlos, CA).   The fragmented and biotin-labeled cDNA was hybridized for 17 hr at 45oC 
to GeneChip Rat Gene 2.0 ST Arrays (Affymetrix, Santa Clara CA). The Rat Gene 2.0 
ST array consisted of 722,254 unique 25-mer oligonucleotide features as the 
representatives of all 26,309 genes in the rats. Specifically, each rat gene is 
represented on the chip by the average of 27 probes along the full transcript length. In 
addition, there are probe sets for several species of non-coding RNAs. In total, each 
chip gave 29,489 probe sets (which we hence for refer to as ~29k). Phycoerythrin-
conjugated streptavidin (Life Technologies, Carlsbad, CA) was used to rinse and stain 
the arrays. The wash and stain procedure were conducted in a Fluidics Station 450 
(Affymetrix) based on the manufacturer’s instructions. The determination of 
fluorescence intensities was performed by a GCS 3000 7G high-resolution confocal 
laser scanner. Data was processed in Affymetrix GeneChip Operating Software suite, 
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v.3.2. (GCOS; Affymetrix). Quality controls used GCOS quality control metrics which 
consisted in mean expression of all arrays box plots and also box plots relative level of 
expression. 
Digital PCR: qPCR assays were conducted with molecular probes for 
sequences in dap, lysA, and thr transcripts in the PolyA Control RNA (Affymetrix). The 
probes were 5' 6-FAM labeled fluorescent probes with internal ZEN and 3' Iowa Black® 
FQ quenchers modification (Integrated DNA Technologies, Coralville IA). The 
sequences of the primers was: dap primer (forward/reverse): 
CTGAAGCAGCCCGCATATTA: GACCGAATTGCCTGATCACT; dap probe sequence: 
ATTCAGCTAACGCTTCCAGACCGC; lysA primer (forward/reverse): 
CTGAAAGCACAGGTGGCATA:CTCCTCCGGATACGACATCTAA; lysA probe 
sequence: TCAGTCGCAATGATTCAGCTCGCT; thr primer (forward/reverse): 
TCACATTGCCGACTGATGAA: GGGAACAGTGACAGAGAACAG; thr probe sequence: 
CCCGTGTATGAACGAAGCCGACAT; A TaqMan® Gene Expression Assay containing 
a 5' 6-FAM/3" MGB quencher modified probe (Rn_99999916) was used to detect 
Gapdh transcripts (Life Technologies, Carlsbad CA). Digital PCR was generated by 
using the Biomark HD system, which used qdPCR 37K IFC arrays (Fluidigm, South San 
Francisco, CA). This allowed standard PCR conditions, as per vendor 
recommendations. The efficiency of qPCR assay and reverse transcription reaction 
were based from standard curves calculation to give digital PCR copy numbers. This is 
achieved by a dilution series of pooled cRNA/cDNA and PolyA Control RNA with ten-
fold dilutions. The estimated target copy numbers were plotted against the reported 
relative amounts for all three PolyA Control RNA assays which produced a slope with R2 
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= 0.974. Furthermore, to obtain a detection of digital PCR, cDNA samples were diluted 
at: 0.1X; lys, 1X; thr, 1X; Gapdh, 0.005X.  The estimation for target copy numbers were 
calculated by Fluidigm Digital PCR Analysis Software and changed to copy number 
(CN) per ng RNA by the formula: [No. of Estimated Targets per panel]/[dPCR dilution 
factor x 1.95ng cRNA/panel x RT efficiency (transcript-specific) x dPCR assay efficiency 
(assay-specific)]. PLIER/Quantile-sketch generated microarray signal values (log2 
transformed) for each array were converted to copy number/ng RNA values (log2 
transformed) by linear regression. F-test probability values and r2 values were used to 
choose the model with the best fitness which was a linear fit that did not fix the y-
intercept.  
The final number of microarrays obtained for each group are shown in Table 4. 
As seen, at least 3 replicates of microarrays was achieved for the experimental groups. 
The numbers in parentheses are the number of successful digital PCR samples if 
different from the total number of chips. As seen, 2 of 3 CA1p and only 1 of 3 CA3p 
samples gave successful digital PCR results. For all other samples, the digital PCR was 
successful for each sample. 
Table 4: Number of microarrays for each experimental group.  
 CA1p CA1T CA3p CA3T  
NIC 4 4 4 4  
30m 3(2) 3(1) 3 3  
8R 3 4 4 4  
16R 3 3 3 3  
24R 3 3 3 3  
48R 3 3 3 3  
72R 3 3 3 3 sum total 
total 22 23 23 23 91 
Digital PCR (dPCR) numbers are the same except for two samples 
where dPCR did not work, and the number of successful dPCR 
samples are in parentheses. 
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Microarray data analysis: In the following, it is to be understood that each 
analysis method was performed on both the total and polysome mRNA chips as well as 
on the CA1 and CA3 chips. For the sake of simplicity, these distinctions are omitted 
from the following and the emphasis is placed on relative vs. copy number datasets, 
which required in some instances, different ways to handle the data.  
A. Chip Preprocessing: After Genome Explorations provided the microarray 
data, testing of preprocessing methods was performed by us using the software 
Affymetrix Expression Console (build 1.3.1.187). The software allowed six combinations 
of preprocessing steps, listed in Table 5. The preprocessing methods were: 
1. Probe summation: (a) root mean average (RMA) or (b) probe logarithmic 
intensity error estimation (PLEIR). 
2. Background correction: (a) perfect match (PM), (b) PM/RMA, or (c) PM-
CGBK (CG background correction) 
3. Normalization: (a) Square Quantile (SQ) or (b) general median (GM) 
Table 5: Combinations of microarray preprocessing tested. 
combination Probe summation BKGRND NORM 
1 RMA (median polish) PM/RMA BC SQ 
2 RMA PM/RMA BC GM 
3 PLIER PM SQ 
4 PLIER PM GM 
5 PLIER PM-CGBK SQ 
6 PLIER PM-CGBK GM 
 
Two criteria determined if a preprocessing method was acceptable: (1) how well the 
chips normalized, and (2) detection of hsp70 mRNA since it is well-known that hsp70 
mRNA increases > 100-fold after brain I/R in hippocampus.  
B. Digital PCR: As detailed below in Results section, combination 6 was used to 
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preprocess data. This transformed dataset served as input for the digital PCR (dPCR) 
regression which converted all values from relative light intensity (REL) to copy number 
(CN), as described above in the Digital PCR section.  The REL and CN are each 
standalone datasets for expressing the microarray results.  
D. Differentially Expressed Gene Lists: Table 4 gives the number of chips per 
experimental group.  Conventional microarray analysis was performed on the REL 
dataset using BRB Array Tools123 with no filter applied to the datasets.  Class 
Comparisons Between Groups of Arrays (CCA), as implemented in BRB Array Tools, 
was used to obtain differentially expressed genes (DEGs) at increasing statistical 
stringency. The parameters tested (from least to most stringent) were: (1) p = 0.05/fold-
change > 1.5, (2) p = 0.01/fold-change > 2, and (3) p = 0.001/fold-change > 3.  
C. Probe Averaging: Using custom code written in Matlab, the REL and CN data 
were averaged for each gene per experimental group. For both REL and CN, ratios of 
experimental to control were calculated for each probe set for each experimental group 
(REL x-fold and CN x-fold, respectively). In addition for the CN dataset, (experimental – 
control) was calculated for each experimental group (CN subtract). The ratios or 
differences of the ~29k probe sets amongst experimental groups relative to the NIC 
group served as inputs for calculating multi-dimensional distances (MDD). 
E. Multi-Dimensional Distances: MDD was calculated by the method Huang et 
al111.  MDD is a generalization of the 3 dimensional distance formula in x, y, z 
2 2 2
2 1 2 1 2 1(x x ) (y y ) (z )s z       (12) 
to any number of dimensions, n.  In general, distance, s, is the square root of sum of the 
squares. For n dimensions, Eq. (12) becomes: 
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MDD

   (13) 
This method treats each mRNA (probe set on the chip) as one dimension, so the 
total number of mRNAs gives the total number of dimensions, n.  The total number of 
probe sets was n = 29,489. Eq. (13) was suitable for analyzing the CN subtraction data 
where x2 is one of the reperfused groups and x1 the NIC group. When REL and CN 
datasets were expressed as fold change over NICs, Eq. (13) was modified as follows:  
22
1 1
x( 1)
x
n
i
i
MDD

   (14) 
When a gene does not change, the fold change is 1. In Eq. (14) such a gene will 
contribute zero to the distance.  MDDs were calculated for each experimental group 
using custom code written in Matlab. Three versions of MDD were calculated: 
1. REL MDDs using x-fold change of experimental/NIC (using Eq. 14). 
2. CN MDDs using x-fold change of experimental/NIC (using Eq. 14). 
3. CN MDDs using subtraction of controls from experimentals (using Eq. 13). 
The Matlab code ran according to the following algorithm: 
1. Read in microarray data matrix that had been preprocessed as described 
above (for example, for CA1p REL dataset was 22 columns, one for each 
chip, by 29,489 rows of probe levels). 
2. Calculate average and standard deviation for probes of each experimental 
group. 
3. Calculate MDD from averages as per Eqs. (13) or (14) as suitable. 
4. Rescale MDDs to maximum of 1. 
5. Calculate propagated error for each operation in the MDD formulas from 
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standard deviations; Using Eq. (11), express final error as 95 % 
confidence intervals (2 sigma, or 2). 
As with the PA data, the final MDD values were scaled to the maximum value in 
either CA1 or CA3, which maximum was taken to be 1. The p and T mRNA data were 
scaled independent of each other. The 3 variations of MDD (REL x-fold, CN x-fold, and 
CN subtract) were assessed to determine their consistency with the theoretical 
expectation S.   
3.3 Results 
Animal Surgery and HSP70 detection: On average, 3/4 of the total rats in the 
reperfusion groups showed HSP70 signal in cerebral cortex samples.  Every sample 
was confirmed for HSP70 in cerebral cortex to allow inclusion in the study.  All of 
HSP70 data from samples used for the microarray studies are shown in Appendix B. 
Polysome pellet validation: 
Several methods were done to test 
the quality control of the polysome 
pellet procedure118. Western blot was 
performed and detected ribosome 
markers including ribosome protein 
S6 for 40S and ribosome P antigen 
(RPA) for 60S and polyA binding 
protein and HuR in polysome pellet 
as depicted in Figure 20A. Figure 
20B shows that polysomes pellet 
Figure 20: Western blots and agarose gels. (A) 
Western blot of ribosome markers. (B) Agarose
gel of RNA of polysome pellet. (C) Western blot of
organelle markers. 
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gave an intact ribosomal RNA from RNA extraction procedure.  There is no 
contamination of mitochondria as detected in Western blot in the polysome pellets prep 
by detection using cytochrome C (cyt C), pyruvate decarboxylase (PDC), or cytochrome 
oxidase 4 (COX IV).  Also, the Western blot result also does not show any 
contamination from endoplasmic reticulum, as there is no detection of protein disulfide 
isomerase (PDI).  Finally, it also does not show any nuclear contamination by NeuN 
antibody detection (Figure 20C).  We previously showed approximately 1/3 of the 
protein detected by liquid chromatography tandem mass spectroscopy (LC-MS/MS) 
from the CA1 and CA3 polysome pellets were ribosomal protein subunits118.  These 
control results validated the procedure of polysome pellet isolation.  
RNA quality: RNA capillary electrophoresis showed RNA was good quality for 
microarray procedure with no degradation of rRNA bands. Representative samples from 
the CA1p set are shown in Figure 21.  All samples were required by Genome 
Explorations to pass the capillary electrophoresis test to move forward to microarray 
hybridization.  
Figure 21: RNA capillary 
electrophoresis results 
from Genome 
Explorations from CA1p 
samples from (A) NIC, (B) 
8hR, (C) 24R, and (D) 
48R groups. 
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We independently ran agarose gels in our lab and also observed no degradation 
of RNA samples118.  
Preprocessing Tests: A typical microarray study will report using the RMA 
methods for preprocessing, which is suitable for conventional bioinformatics. Since we 
needed to use the microarray data to calculate MDD, which is not a typical application, 
we evaluated the various preprocessing methods (Table 5) to test how well chips 
normalized and the detection of hsp70 mRNA.  As seen in Figure 22, when a 
normalization method was successful, the chip histograms lay on top of each other. This 
only occurred with combinations 1, 3, and 5 (green check marks in histograms). Only 2 
of the combinations, numbers 5 and 6, detected hsp70 as shown by plots of hsp70 
levels as a function of reperfusion time.  Only combination 5, consisting of PLIER, PM-
CGBK, and SQ, satisfied both of our test criteria. Therefore, all chips were 
preprocessed with this combination.   
 
Figure 22: Results of chip preprocessing tests. Left plots are chip histograms, right 
plots are the relative levels of hsp70 as a function of reperfusion time.  
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Figure 23A shows box blots from preprocessing all microarrays simultaneously.  
Only one sample visibly deviated from the normalization mean (red arrow), but was not 
considered statistically different by the software and hence retained.  Because the total 
RNA and polysome RNA chips derived from different homogenate fractions, it is not 
advised to preprocess the p and T chips together. Therefore, the CA1p and CA3p chips 
(Figure 23B) were preprocessed (Figure 23C) separately from the CA1T and CA3T 
chips (Figures 23D and 23E, before and after preprocessing). When this was done, no 
outliers were observed.  
 
Figure 23: Box plot of microarrays. (A) All 91 chips. CA1p and CA3p (B) before and 
(C) after normalization. CA1T and CA3T chips (D) before and (E) after normalization. 
The chip names are omitted because they are unreadable in these plots. 
 
Estimating S: The final results of the three methods used to estimate S as MDD 
are shown in Figure 24. The top, middle, and bottom rows are REL x-fold, CN x-fold, 
and CN subtraction methods of calculating MDD, respectively. Left figures are polysome 
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RNA and right are total RNA.  The lines connecting the points are splines generated by 
Microsoft Excel graphing software and are presented only to help visualize the data, but 
the curves should not be taken as meaningful. The goal of Aim 3 will be to determine if 
the points shown provide estimates of S time courses that fit curves generated by the 
theory equations. 
 
Figure 24: MDD calculated for relative ratio microarray data. Error bars are + 2. 
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In this section, we give qualitative analysis of the results by comparing the area 
under the curve (AUC) of each spline, calculated using the Matlab trapz function that 
performs a trapezoidal approximation of the area under the curve of a set of data points.  
The magnitude of the AUC allows us to speak of one curve as “greater” or “lesser” than 
another.  As seen in Table 6, for all three MDD calculation methods on polysome RNA, 
the AUC was greater for CA3 than for CA1 (e.g. curves in Figure 24A, C, & E). For total 
RNA, the ratio MDD methods (Figure 24B & D), gave AUC for CA1 greater than CA3.  
For the subtraction method on total RNA, the AUC for CA3 was greater than that of 
CA1. 
Table 6: Area under the curves for plots in Figure 18 
CA1p CA3p CA1T CA3T 
REL 32.1 37.8 57.0 41.2 
CN 23.1 24.5 36.4 23.0 
CN subtract 26.4 30.0 37.4 45.1 
The initial conclusion from these results is that, as was hypothesized, the MDD 
points derived from polysome RNA better fit the theory. CA1 dies but CA3 survives 10 
min global ischemia. The theory indicates that the D time course for CA1 should be 
greater than CA3, and that the S time course for CA3 should be greater than CA1.  For 
the total RNA using the x-fold methods (Figure 24B and 24D) the result opposite of what 
the theory predicts is obtained. As a first pass, this data treatment is encouraging by 
supporting the hypothesis and suggesting that MDD obtained from polysome RNAs may 
be a reasonable estimate of S.  This topic is addressed in greater detail in Chapter 4, 
where the goal of Aim 3 is to fit the PA measurements and the MDDs to time course 
curves calculated from the theory equations. 
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MDD Compared to Differentially Expressed Genes: To determine the validity 
of the MDD calculations, we wished to compare conventional microarray analysis to the 
MDD values. Class Comparisons Between Groups of Arrays (CCA, implemented in 
BRB Array Tools), the conventional analysis method used here, produces list of DEGs 
that clear statistically at predefined p values and x-fold cut off criteria. The resulting 
DEG lists give (a) gene names, (b) the x-fold difference with the control group, and (c) 
the related statistics meeting the predefined criteria. CCA and other widely used 
methods such as significance analysis of microarrays (SAM) use special statistical 
methods, such as false discovery rates (FDRs) to account for the facts that microarrays 
have a low number of replicates but a large numbers of individual observations in the 
form of thousands of probe sets per microarray.   Since the MDD method does not use 
the more refined statistics, it was important to compare the two approaches. The way 
we compared the methods was to generate DEG lists, and from the genes on the list, 
calculate a list-MDD and determine how that number compared to MDD as calculated 
above.  
To compare the CCA results to the MDD method, CCA was run on the REL 
dataset to generate DEG lists at increasingly stringent selection criteria. The three 
selection criteria tested from least to most stringent were: (1) p = 0.05, x-fold > 1.5, (2) 
p= 0.01, x-fold > 2, and (1) p = 0.001, x-fold > 3. A schematic illustrating the analysis 
protocol is shown in Figure 25 for the comparison of the 30mR group to the NIC group 
for the CA1p REL data. The comparison shown is 30mR/NIC, run three times at the 
indicated stringencies, which produced three gene lists of DEGs. The image is meant to 
illustrate that, as stringency weakens, the CCA method captures larger lists of genes. 
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CCA was run also for 8R/NIC, 16R/NIC, 24R/NIC, 48R/NIC, and 72R/N. For each 
comparison, 3 lists were produced, leading to a total of 18 DEG lists for CA1p, and 18 
lists for each of CA3p, CA1T, and CA3T, for a total of 18 x 4 = 72 DEG lists generated 
in this analysis.  
Each of the 72 CCA DEGs lists provided a list of genes, and also the x-fold 
difference of that gene with the control group. The x-fold differences on a given list 
could be plugged into Eq. (14) to generate a “list-MDD” for that DEG list. Thus, 72 DEG 
“list-MDDs” were calculated.  In turn, the list-MDD could be compared to the MDD as 
calculated by Eq. (14) that used all 29,489 probes on the microarray chips. Clearly, a 
list-MDD will be smaller and be some percentage of the MDD calculated by Eq. (14).  
The percentages were calculated and tabulated, along with the number of DEGs 
detected at each stringency, and what percent of the 29,489 probes the DEG list 
represented.  Averages were taken per stringency, and the final results are tabulated in 
Table 7. 
Figure 25: Overview of CCA tests 
performed on REL dataset. Shown is 
the comparison of the 30mR group to the 
NIC control group for the CA1p subset of 
the REL dataset. List 1 has n DEGs, list 2 
has m DEGs and list 3 has o DEGs 
where n < m < o. 
 
 
 
 
 
 
N, 30mR, 8R, 16R, 24R, 48R, 72R 
p    0.001  0.01  0.05
list 1
g1
g2
…
gn
list 2
g1
g2
g3
…
gm
list 3
g1
g2
g3
g4
…
go
CA1p:
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Table 7: Comparison of CCA and MDD.  
 1.5 (0.05) 2(0.01) 3(0.001) 
% list-MDD/MDD 81% + 11% 65% + 14% 48% + 14% 
# DEGs 2584 + 620 498 + 191 64 + 43 
% of all PS 8.8% + 2.1% 1.7% + 0.8% 0.2% + 0.15% 
Row 1 is the percent of list-MDD to total MDD using all genes. Row 2 is the number of genes per DEG 
list. Row 3 is the percent of the # of DEGs out of all 29,289 probes on the chips. Column headings are the 
stringency criteria: x-fold cutoff (p value). All values are means + standard deviations. 
As seen in Table 7, at p = 0.05 with 1.5 fold cutoff, on average, CCA detected 
~2500 DEGs across all experimental group comparisons with the controls. As expected, 
the number of differentially expressed genes decreased with increasing stringency, 
decreasing to ~500, and ~65 at p = 0.01 and 0.001, respectively. These numbers of 
genes represent about 9%, 2% and 0.2% of all genes on the microarray.  The 
corresponding list-MDDs account for ~80%, ~65%, and ~50% of the MDD calculated 
using all 29,489 probes.  
When it is considered that CCA criteria of p < 0.05 and cutoff of 1.5 most closely 
approximate the parameters used in many conventional microarray studies, we can 
conclude that about 80% of the MDD used in to generate the Figures 18A and 18B 
would be detected by conventional microarray analysis. The remaining 20% would be 
considered statistical noise and discarded by conventional methods. However, we have 
posited that D and S form networks in the cell, and with our calculation of MDD using all 
29,489 probes, we can alternatively interpret the 20% as low intensity network 
components that are missed by convention microarray analysis. The present studies 
provide no evidence to support or refute this interpretation, but our analysis here raises 
this alternative possibility. 
In conclusion, this section has developed some concrete evidence that using 
MDDs as we have in this study give results consistent with a typical microarray analysis 
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by showing that a typical microarray analysis would detect ~80% of the signal we 
obtained with the MDD calculation that used every gene on the microarray.  We 
consider this an initial validation of the MDD values plotted in Figure 26, which justified 
moving forward to fit this data to the mathematical equations of the acute injury theory. 
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CHAPTER 4 - FITTING THE DATA TO THE THEORY 
4.1 Introduction 
Aim 1 estimated D as a function of time in CA1 and CA3 by measuring levels of 
PAs following 10 min of global brain ischemia and a time course to 72 hr of reperfusion. 
Aim 2 estimated S in CA1 and CA3 by quantifying changes in polysome mRNAs along 
the same time course. The measurement of PAs by densitometry gave a single final 
answer but there were alternate ways to process the microarray data giving three 
possible estimates of S. The three methods were: (1) REL x-fold, (2) CN x-fold, and (3) 
CN subtraction.  Combining the PA data with each of the three MA analyses gave three 
final data sets of the estimates of D and S as a function of time, which are displayed in 
Figure 26.  In the 1st and 2nd columns are the CA1 and CA3 D and S time course 
estimates, respectively. The 3rd column plots D versus S to give the trajectories of CA1 
and CA3.  The curves depicted in Figure 26 are spline fits automatically generated by 
MS Excel but these are not theoretically-relevant curves passing through the data 
points.  The goal of Aim 3 is to determine if the theoretical equations can provide curves 
that pass through the data points, within the specified 2 error.  
4.2 Overview of Aim 3 
To achieve the goal of Aim 3 requires expanding the theory to better account for 
cell injury. Chapter 1 described the single injury autonomous model, where 
“autonomous” is a technical mathematical term meaning that time, t, is absent from the 
right hand side of an ordinary differential equation. The autonomous model has 
limitations that make it a poor candidate for fitting experimental data. Therefore, 
described ahead is the nonautonomous single injury model (SIM), which is a more 
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realistic model of cell injury. The SIM allows construction of multi-injury models (MIM).  
We will then compare the trajectories from the SIM to the data trajectories (third column, 
Figure 26) as a decision criteria for which dataset to fit. We show below that our present 
best fit of the experimental data points used a MIM construction. We close this chapter 
with an analysis of the microarray data using an independent method called MaSigPro 
that detects time course trends in microarray data and provides some justification for 
the use of the MIM to fit the data.  
 
Figure 26: Final D and S estimate data sets. (A) REL x-fold; (B) CN x-fold; (C) CN 
subtraction. Columns 1 and 2 are CA1and CA3 D and S time course estimates, 
respectively. Column 3 are D/S trajectories. All error bars are +2. 
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4.3 Critique of the Autonomous Model 
In Chapter 1 it was discussed how the autonomous model requires 
concatenation (“gluing”) of two separate systems of ODEs to generate a theory that 
accounts for how injured cells recover or die.  The figure is repeated as Figure 27.  The 
main theory equations (Eq. (1), Chapter 1) generate time courses that end in attractor 
states.  The attractor states represent the maximum deviation from the control state. 
However, the system stays at the attractor for all time after achieving this state, which is 
unrealistic for cell injury.  Instead, we would expect, at a given magnitude of injury, I, 
that the system would deviate to a maximal state away from control, where there is 
maximum buildup 
 
Figure 27: Illustrating the need to concatenate two ODE systems to generate 
“uphill” and “downhill” components of an injury time course. 
 
of damage or stress responses at some time t after then injury. But after this point, we 
expect the system to either recover or die. That means the system must return to (D, S) 
= (0, 0) where there is no damage or stress responses in the cell. This would happen if 
the cell recovered (S* > D*) or if the cell died (D* > S*). In the autonomous model, this 
problem is dealt with by making an artificial assumption that when the injured system 
hits the attractor state (D*, S*) that immediately Eq. (1) no longer applies and a second 
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(15) 
ODE system, the “downhill” ODE (Figure 27) takes over. The second ODE system 
describes the exponential decay from (D*, S*) to (0, 0), where the rate of decay is given 
by |D* -S* |, as illustrated in Figure 21. It is preferred to have a system of differential 
equations where all of this happens in one system and does not require artificially 
“gluing’ two ODE systems together, and this was the motivation for developing the 
nonautonomous SIM version of the theory. 
4.4 The Nonautonomous Single Injury Model 
The nonautonomous single injury model (SIM) comes from modifying postulates 
5 and 6 of the autonomous model.  For the autonomous model, those postulates were: 
Postulate 5: The velocity parameter v is constant equal to 1. 
Postulate 6: The decay parameter k is constant equal to 1. 
Postulate 5 is unrealistic because it says the rate constant governing the 
formation of D and S is a constant which does not change with time. This implies that 
the formation of D and S would be constant with time, which means they would continue 
to build up without limit, after injury of magnitude I occurred. In reality, both D and S 
build up for some amount of time, each reaching some maximum, and decay thereafter, 
whether the cell lives or dies. Therefore, we modify postulate 5 to be more realistic by 
saying that the rate of buildup of D and S decays as a function of time.  The simplest 
mathematical form is exponential decay. Therefore the new postulate 5 for the SIM is: 
1
0
c t
D Sv v v e
   
Eq. (15) says that the rate of formation of D and S is not constant, but decreases 
exponentially with time.  
Postulate 6 of the autonomous model said the decay parameter k = 1. Like the v 
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(16) 
(17) 
parameter, this is unrealistic because it says that decay is a simple exponential function 
of D for the D ODE, and of S for the S ODE in the autonomous version. Although 
concatenating two equations, shown in Figure 27, was artificial, it was an important step 
to understand how k behaves. Instead of taking an exponential decay at (D*, S*) where 
the decay rate equals |D - S|, this result suggested that k should be a function of the 
instantaneous value of |D-S | as follows: 
2 | |D Sk k c D S    
We can then substitute these into the autonomous model to give the SIM version 
of the theory: 
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To summarize, this non-autonomous version of the theory allows for a full 
progression of the injury trajectory in the phase plane, starting at (0, 0) and naturally 
ending at (0, 0) and overcomes the problem of the artificial concatenation of two ODE 
systems as illustrated in Figure 27.  Comparison of the SIM to the autonomous model is 
shown in Figure 28, where the SIM generates true closed loop trajectories that begin 
and end at (D, S) = (0, 0).  
4.5 Multi-injury Models 
The SIM, Eq. (17), possess an additional advantage. It allows construction of 
multiple injury models (MIM) where the first injury occurs at time t = 0 and another injury 
can occur any time after.  This is important because it allows the theory to model such 
phenomena as preconditioning and post-conditioning, both of which are forms of 
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sequential injuries in time.  For preconditioning, a sublethal injury Isublethal, is applied at 
time zero, t0, and the lethal injury Ilethal, is applied at some later time. It is well-known that 
preconditioning prevents the 2nd, lethal injury from being lethal. 
 
Figure 28: Comparing SIM output to the autonomous model. (A) Autonomous 
model: green trajectory is “uphill” output of Eq. (1). The blue line is what the trajectory 
from the “downhill” ODE system would look like overlaid on the uphill phase plane to 
make a closed loop trajectory. (B) A true closed loop trajectory from the SIM of Eq. (17), 
where I < IX, thus the system survives. Arrows depict the forward time evolution of the 
trajectory. (C)  The D (red) and S (green) time courses corresponding to the trajectory in 
B.  
A MIM also allows modeling of post-injury therapeutics, where the therapy is 
treated as a sublethal injury. This is seen, for example, in hypothermia, which is a very 
effective form of therapy for many forms of ischemia, including brain ischemia. 
Hypothermia is indeed an injury as described by Eq. (17), where the temperature 
decrement represents the intensity of injury, I.  If hypothermia is too intense (high I = 
large temperature decrease), it is lethal. If the temperature decrement is below IX, the 
system will recover from the insult. A MIM can, in principle, model the 1st injury, say 
brain ischemia, at time zero, t0, and then model the application of hypothermia at a later 
time, t1.  
There are many possible ways to use Eq. (17) to construct a MIM. Here we 
construct one based on minimal assumptions that the D and S generated in the 2nd 
injury add to the D and S generated in the 1st injury.  Since there are two sequential 
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(18) 
(19) 
injuries, we call this a 2-MIM. It consists of 2 instances of the SIM added in the following 
fashion: 
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Where 
2 1 2 1 2| ( ) ( )|k c D D S S     
As seen in Eq. (18), the D and S values from injury 1 and injury 2 add in both the 
formation and decay terms.  Figure 29 shows the circuit diagram corresponding to Eqs. 
(18) and (19). Figure 30 shows a computation of the 2-MIM that mimics a 
preconditioning response.  
 
Figure 29: Circuit diagram of the 2-MIM given by Eqs. (18) 
and (19). I1 is applied at t0 and I2 is applied at t1. 
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Figure 30: Solutions of a 2-MIM that model preconditioning. D and S time courses 
are red and green, respectively. A sublethal injury is given at t0 and a lethal injury 
applied at (A) t = 250, (B) t = 72, and (C) t = 48. When the time between I1 and I2 is 
small enough, I1 and I2 interact and the first injury causes the second injury to no longer 
be lethal.  
 
4.6 Materials and Methods 
Custom code was written in Matlab (ver. R2017a) to fit the rescaled experimental 
data to the SIM and MIM versions of the theory.  MaSigPro analysis of microarray data 
was conducted using custom scripts written for R (ver 3.2.5). Computational details are 
provided below in the relevant sections. 
4.7 Results 
Trajectory Analysis: The first problem to consider is which of the three final 
datasets (Figure 26) to fit. The approach we took to address this was to first evaluate 
how the trajectories corresponded to the theory output.  Figure 31 shows the CA1 (red) 
and CA3 (green) trajectories along with a generic survival and death trajectory 
generated by Eq. (17).  Figure 31A-C are the exact same trajectories shown in Figure 
26 but with the error bars removed so the trajectory paths are easier to see. Figure 31D 
shows a general property of the SIM trajectories. Survival trajectories occupy the plane 
to the left of the diagonal, and death trajectories occupy the plane to the right of the 
diagonal. This is true for any SIM solution expressed as a trajectory.   
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Figure 31: Trajectories for (A) REL x-fold microarray (MA) analysis, (B) CN x-fold MA 
analysis, (C) CN subtraction MA analysis, and (D) generic survival (green) and death 
(red) trajectories generate from the SIM, Eq. (17). Blue dashed line is the diagonal of 
the plane.  
 
When we evaluated the three final datasets, none of them strictly adhered to this 
feature. For REL x-fold (Figure 31A) the 30 min and 72R CA1 data points (red curve) 
are to the left of the diagonal. For both the CN x-fold and CN subtract (Figure 31B and 
C, respectively), the 30 min CA3 data point is right of the diagonal, and the 72R CA1 
point is left of the diagonal. However, for both CN datasets, the error on the 30 min data 
point puts it on both sides of the diagonal (Figure 26). Thus the CN datasets most 
closely adhere to the theoretical curves and we focused on them. Between the CN x-
fold and CN subtract curves, we find the x-fold curves had overall smaller errors (Figure 
26). We therefore focused the analysis on the CN x-fold curves because the smaller 
A B
C D
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errors created a more stringent situation for curve fitting the data to theoretical curves.  
Fit Constraints: Fitting was not arbitrary. The experimental design dictated 
some parameter relationships and the known outcome of CA1 and CA3 neurons 
dictated others. The following list of fit constraints determined numerical choices for 
equation parameters.  
1. cD and D had to be equal for CA1 and CA3 because both were subjected 
to the same global ischemic insult.  
2. I had to be equal for both CA1 and CA3 because both were subjected to 
the same 10 min intensity of ischemia. 
3. cS for CA3 > cS for CA1 because CA3 survives the I intensity of 10 min 
ischemia and/or 
4. D for CA3 < D for CA1 because CA3 survives the I intensity of 10 min 
ischemia. 
5. IX for CA1 had to be less than the I value for the fitting because CA1 dies. 
6. IX for CA3 had to be greater than the I value of the fitting because CA3 
survives. 
Curve Fitting:  For this Dissertation analysis, the curve fitting was performed “by 
eye” and using a least squares measure as an indicator of the fit quality. More 
sophisticated means of data fitting were not employed for this Dissertation, and the 
reasons for this are discussed in Chapter 5, Discussion.   A fit to the SIM is shown in 
Figure 32, and the model parameters corresponding to the fit curves are listed in Table 
8.  The closer to zero are the least squares, the better the fit.  The SIM did not give a 
particularly good fit for either CA1 or CA3. For CA1, the least squares for the D time 
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course (LSD) was 0.55, and the LSS = 0.32. For CA3, LSD = 0.38 and LSS = 0.94.  In 
Figure 26A, for CA1, the D time course ends in the 72R S point and the S time course 
ends in the 72R D point.  The fit is also poor for CA3 where the 24R and 72R S points 
were not even approached by the fit curves (Figure 32C, two blue S points outside of 
curves).  Expectedly then, the data points did not fall on the corresponding trajectories 
(Figure 32B and D).  
Figure 33 shows data fits to the MIM. For these fits, CA1 was fit to a 2-MIM and 
CA3 was fit to a 3-MIM. The parameters corresponding to the fitting curves are listed in 
Table 9. For CA1, LSD = 0.4 and LSS = 0.3, slightly better than the SIM fits. For CA3, 
LSD = 0.14 and LSS = 0.14, significantly better than the SIM fits. Fitting to the MIM 
makes the unusual assumption that the additional injuries, I2 in the case of CA1, and I2 
and I3 in the case of CA3, were not due to an exogenous insult, but were endogenous 
to the tissue.  For both CA1 and CA3, the additional injuries had the same core 
parameters (cD, D, cS, S) and varied only in the SIM parameters v0, c1, and c2, 
suggesting they are due to the same mechanism, just expressed with different kinetics.  
This topic will be further discussed in Chapter 5. 
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Figure 32: SIM fit to CN x-fold data estimates of D (magenta points in A and C, red 
points in B and D) and S (blue points in A and C, green points in B and D).  (A) CA1 D 
(red) and S (green) time course curves, and (B) corresponding CA1 trajectory. (C) CA3 
D (red) and S (green) time course curves, and (D) corresponding CA3 trajectory. All 
error bars are + 2, omitted from trajectories for clarity. 
 
Table 8: Parameters obtained from curve fits in Figure 26.  
 cD D cS S v0 c1 c2 n 
CA1 0.04 0.02 1.5 0.25 0.175 0.05 0.125 3 
CA3 0.04 0.02 3 0.2 0.35 0.2 0.4 3 
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Figure 33: MIM fits to CN x-fold data estimates of D (magenta points in A and C, red 
points in B and D) and S (blue points in A and C, green points in B and D).  (A) CA1 D 
(red) and S (green) time course curves, and (B) corresponding CA1 trajectory. (C) CA3 
D (red) and S (green) time course curves, and (D) corresponding CA3 trajectory. All 
error bars are + 2. CA1 was fit with a 2-MIM, where I2 occurs at 60 hours. CA3 was fit 
with a 3-MIM where I2 occurs at 14 hours and I3 at 60 hours.  
 
 
Table 9: Parameters obtained from curve fits in Figure 27.  
  cD D cS S v0 c1 c2 n 
CA1 I1 0.02 0.02 0.29 0.25 1.75 0.09 0.011 3 
 I2 0.001 0.015 0.5 0.1 1.5 0.1 2.5 3 
CA3 I1 0.02 0.02 0.5 0.2 0.2 0.75 0.018 3 
 I2 0.001 0.015 0.5 0.1 1.5 0.15 1 3 
 I3 0.001 0.015 0.5 0.1 1.5 0.3 1.5 3 
  
A B
C D
81 
 
MaSigPro Gene Expression Time Courses:  We sought an unbiased approach 
to complement the initial approach to fit the data points “by eye”. The microarray data 
collected in this study is time dependent. Analysis methods such CCA (used in Chapter 
3) are not suitable for analyzing time course microarray data. CCA and related methods 
are designed to compare two conditions, for example, a drug treated and untreated 
sample, and time is not a consideration in the underlying statistics.  Analysis of time 
courses of microarray data require some means to take into account the time aspect of 
the study. Three major methods have been developed to analyze microarrays time 
courses. ANOVA based methods treat time as one of the study factors. A second 
method utilizes Bayesian statistics and updates expected frequencies based on 
observed frequencies as time progresses. A third method seeks to cluster genes based 
on how they change over time, which is the method we used here as implemented in 
MaSigPro124. MaSigPro is a two-step analysis method. In step one, statistical 
significance of differentially expressed genes are determined. In step two, polynomial 
splines are constructed based on how a given gene changes over time. Then, genes 
with statistically similar polynomial splines are clustered together.  This method allows 
determination of groups of genes that may increase together, decrease together, or 
generally, follow the same pattern of change over time.  The clusters then can be 
subject to Gene Ontology analysis to identify enriched genes, pathways, biological 
processes and so on.  
MaSigPro analysis was run on the REL x-fold data set because this method 
requires a minimum of n = 3 observations per gene and the CN data could not meet this 
criteria due to the unsuccessful dPCR of some of the 30mR samples (Table 4).  The 
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software was set to output 9 time course clusters for both CA1 and CA3.  We next found 
clusters in CA1 and CA3 that had similar temporal profiles and grouped them into 7 
different groups labeled A-G (Figure 34 through Figure 38). Then, each cluster was 
analyzed for gene enrichment using the Web-based Gene Set Analysis Tool-Kit 
(WebGestalt: http://www.webgestalt.org). Finally, the enrichment profiles were 
compared for each of the groups A-G between CA1 and CA3.  
A total of 1711 genes were clustered in both CA1 and CA3. The number of genes 
in each cluster is shown on each cluster plot in Figure 34 through Figure 38. Group A 
represented genes that decreased below controls for the 72 hr duration. Group B genes 
were below or at NIC levels then peaked in the 8 – 16 hr range, and persisted for the 72 
hr time course. Group C genes were at or higher than control, again peaked in the 16 hr 
range, then declined thereafter. Group D genes showed a continuous increase over the 
72 hr reperfusion period. Group E genes peaked at 16 hrs, declined to 48 hrs, then 
peaked again at 72 hrs. Group F genes started out higher than control, then 
continuously declined below control levels by 72 hr. Group G genes were at or below 
control, then increased rapidly at 16 hrs, persisted to 48 hrs then declined at or below 
control levels by 72 hrs.  
Table 10 details some of the pathways associated with each group. In general 
these were different between CA1 and CA3, in spite of following similar time courses, 
although there was also some overlap in pathways (highlighted terms, Table 10). It is 
not our intent to focus on specific pathways per se, but to point out that this unbiased 
MaSigPro analysis lends some support for the use of the MIM to model our data. 
Specifically, Groups B, C, E, and G support transient activation events from ~ 8 – 16 hrs 
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reperfusion. Group E (representing 117 genes in CA1 and 188 genes in CA3) also 
supports a second activation event after 48 hrs. While not constituting proof for 
endogenous injuries modeled by the MIM, these time course groupings support that 
relatively discreet events happened in the 8-16 hr time frame, and again in the 48-72 hr 
time frame, which is consistent with times chosen for additional MIM injuries used to fit 
CA1 (I2 at 60 hr) and CA3 data (I2 at 14 hr and I3 at 60 hr).  
 
Figure 34: Group A clusters detected by MaSigPro. Each Group consists of similar 
time course clusters between CA1 (red) and CA3 (green). Red lines are control levels. 
Green lines are composites of the time course changes of the clustered genes. 
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Figure 35: Group B clusters detected by MaSigPro.  
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Figure 36: Groups C & D clusters detected by MaSigPro.  
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Figure 37: Group E clusters detected by MaSigPro.  
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Figure 38: Groups F and G clusters detected by MaSigPro.  
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Table 10: Enriched genes in the clusters in Groups A-G in CA1 and CA3.  
Group Temporal Behavior CA1 pathways CA3 pathways 
A Continuous decline below NIC ion channels MAP kinase 
 ATPases apoptosis 
 ion transporters IL7 - B/T cells 
B Increase over NIC by 8hr, peak 16-24 
hr, stays elevated over 72 hr.  
inflammation notch 
 cytokines cytokines 
 sugar & fat metabolism amino acid metabolism 
  histamine receptors CSF macrophage 
   heat shock 
   interleukin 
   stress responses 
   cytochrome p450 
   PLA2 
   prostaglandins 
   glutathione 
C Increase over NIC 16-24 hr, declines 
thereafter 
tRNA synthesis lysosome 
 heat shock  heat shock 
 stress responses 
D Continuous increase over NIC B cell Platelet  
  lipid PLA2 complement 
  apoptosis lipid PLA2 
  interferon apoptosis 
  Platelet   
  cell cycle  
  complement  
E Peaks at 16 hr, declines to NIC by 
48R, peaks again at 72 hr 
cytokines olfactory receptors 
 ion channels lipid metabolism 
  amino acid metabolism antioxidant response 
   terpenoids 
   glycans 
F Starts higher than NIC, continuous 
decline to below NIC over 72 hr 
FOS, IEGs DAG/prostaglandins 
 cAMP signaling PI3/glycans 
 lipid enzymes carbonic anhydrase 
G Starts below NIC, peaks at 24 hr, 
declines to or below NIC at 72 hrs 
alpha crystallin stress 
response 
antioxidant response 
 RAS signaling 
The specific gene ontology terms are not used here. Instead, pathway names are given that give an 
overall functional view of the enriched genes. Pathways common to CA1 and CA3 are highlighted. 
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CHAPTER 5 - DISCUSSION AND CONCLUSIONS 
5.1 Overview of Discussion 
To our knowledge, this is the first ever study to attempt to quantify cell injury 
using theoretical equations designed to capture the dynamics of how injured cells 
change as a function of time and injury intensity.  It was not the intent of this 
Dissertation to test or validate the nonlinear theory of acute cell injury. Instead, the goal 
of all three Aims revolved around the need to find quantitative estimates of the two 
theory variables D and S.  The ability to quantify D and S necessarily precedes any 
attempt to test the theory itself.  To this end, Aim 1 hypothesized that the levels of PAs 
would estimate the change of D with time.  Aim 2 hypothesized that changes in 
polysomal mRNAs would estimate S with time.  Aim 3 hypothesized that these 
experimental estimates of D and S could be fit by time course solutions of the theory 
equations.  
Given the germinal nature of the studies described here, we cannot state 
unambiguously that the efforts were a success or failure. Perhaps the best indicator 
along these lines are the trajectories depicted Figure 31 (Chapter 4).  Although the 
trajectories of our experimental data are not an ideal quantitative fit to the theory, the 
general form of the trajectories is what one would expect based on the solutions of the 
theory, particularly the MIM variants. This result provides us with cautious optimism that 
the work described here is not wholly incorrect, and, in fact, may be on the right track. 
We discuss several issues here including: (1) technical issues with estimating D 
and S by PAs and polysome-bound mRNA, respectively, (2) technical issues with data 
fitting, and (3) comments about the use of the MIM to fit the data. After these 
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discussions, we give future directions ((1) The use of a mathematical framework to 
understand biomedical results, (2) what would be entailed to actually confirm or refute 
the theory once it is known how to measure D and S), and then offer concluding 
remarks. 
5.2 Technical Issues Estimating D and S  
The first attempt to measure D and S reported here almost has a chicken or egg 
quality. We cannot validate our measures of D and S unless we have independent 
measures of D and S to compare them against. But this is the first attempt to measure 
D and S, so there is nothing else to directly compare them against. However, it is not a 
true chicken or egg problem because decades of detailed biomedical research has 
demonstrated beyond a shadow of a doubt that after injury cells (1) contain molecules 
they did not contain before the injury, which are damage products, and (2) the cells 
express numerous stress responses intended to protect and repair the cell. Thus, the 
concepts underlying D and S are sound. However, because this is the first attempt to 
estimate their numerical values, there is no external validator and we can only discuss 
our measures with respect to what is known of the detailed molecular biology.  
Estimating D with PAs: The estimates of D (Figure 18) seem to be on 
reasonable footing.  The final result shown in Figure 18 tallies with theoretical 
considerations.  That is, there should be a lot of D in CA1 that will die, and there should 
be less D in CA3 that survives.  This is indeed the result measured.  The measure itself, 
PAs, are known to be the end product of several upstream damage pathways including 
loss of ATP, and altered ionic strength, pH, and redox status, all of which occur with 
brain ischemia.  Thus, PAs may well track the total amount of damage in the cells, even 
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if the levels of PAs are only a specific percentage of this total damage. Tracking the 
change in time was the important feature to match to theory solutions. The qualitative 
difference between CA1 and CA3 is consistent with the theory solutions. 
The CA1 and CA3 time courses were determined as carefully as possible, but we 
note the error bars for CA1 PAs were substantially greater than CA3 PAs. This can be 
accounted for by the theory. It is well-known that 10 min ischemia is close to the tipping 
point amount of ischemia that kills CA1 neurons, but below that needed to kill CA3 
neurons. It is possible some of the rats were just below and some just above the CA1 
tipping point due to the vagaries of the surgical procedures. A small difference in core or 
head temperature, or the rate at which blood was reinfused in the animals could make a 
large difference near the tipping point. In other words, some CA1 entered into the study 
might have been slightly below the tipping point, and would have survived. Such 
animals would still make copious HSP70 and not be excluded from the study. If indeed 
the CA1 PAs were a mixture of cells slightly below and slightly above the tipping point, 
we would indeed expect large variances in our results, which is what was observed. On 
the other hand, CA3 was well below its tipping point and provided a more homogeneous 
sample where all CA3s entered into the study would survive, and we observed smaller 
errors with CA3 PAs. 
Estimating S with Polysome mRNAs:  Clearly the same concern of proximity to 
the tipping point pertains to our measurements of gene expression as it does with the 
PA measurements. But there is another factor making polysome-bound mRNAs as less 
than optimal indicators of S than PAs were of D. This was mentioned in the Introduction: 
there are many gene-independent stress responses completely excluded from our 
92 
 
method for estimating S. The gene independent stress responses include all of the pre-
existing machinery in cells which respond to injury.  Some examples include stress 
dependent signaling systems such as AMP kinase that responds to low levels of ATP, 
or the stress activated protein kinases (SAPKs), members of the mitogen-activated 
protein kinase family. In the Introduction was mentioned the taurine system activated in 
response to hyperosmotic intracellular conditions. In general, these are transcription-
independent, early response systems that respond immediately to cell injury. Over time, 
gene dependent systems may come to dominate S due to the time it takes to activate 
stress gene transcription and translation. These considerations suggest that our 
estimates of S early in the time courses, at 30 min and 8 hr reperfusion, were probably 
low compared to the real value.  One means to deal with this would be to perform 
phosphoproteomics in conjunction with the microarrays, under the expectation that 
early, transcription-independent stress responses would involve substantial changes in 
protein phosphorylation as stress signals are conveyed throughout the injured cells.  
5.3 Data Fitting 
The main strategy to determine if our measures of D and S were plausible was to 
compare them to time course/trajectory solutions output by the theory equations and 
determine if there was a best fit within a prescribed statistical significance, which was 
2 in the present study. When viewing the SIM (Figure 32) and MIM (Figure 33) fits, it 
must be kept in mind that points where the error bars overlapped the curve indeed fit 
the curve to a 2 level of significance. However, for the SIM fits, there were points in 
both CA1 and CA3 that did not fall on either the computed D or S time courses (Figure 
32A and 24C).  That all the data points did not fall on the line brings into question the 
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quality of the fits. This could be due to either (1) choosing the wrong parameters, or (2) 
the specific form of the theory equations being incorrect to fit the data.    
A related point of great importance has to do with sampling. Each time course 
extended over 72 hours, but each only consisted of 7 time points. This is an extremely 
sparse sampling. However, the experiments involved large numbers of rats, and 
(relatively) expensive microarray technology, and it was not possible within the budget 
of the experiments to sample more points. Clearly, if more points were available, the 
nature of the dynamical curve would be better revealed, and it would be easier to 
formulate equations that produced matching forms.  
There are automated methods for curve fitting nonlinear equations. One such 
method our group has worked with is the Nelder-Mead simplex method, widely used in 
physics and engineering to determine parameters for nonlinear differential equations.  
We did not report these results in this Dissertation because the work is still in early 
stages. One important lesson we have learned so far is that automatic fitting is not a 
panacea but has its own limitations and pitfalls. The most important pitfall is that any 
such method must be “seeded” with starting values of the parameters. The algorithm 
starts from the seed parameters then systematically alters and retests the parameters, 
while trying to minimize a least squares measure.  The autonomous theory has five 
parameters (cD, D, cS, S, and I).  The SIM adds three additional parameters (v0, c1, c2) 
for a total of 8. A 2-MIM doubles the number of parameters to 16, a 3-MIM triples them 
to 24, and so on.  
A common situation in using methods that require seeding in this fashion is the 
possibility that the algorithm will diverge away from the desired solution.  This 
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divergence occurs in an algorithm as apparently simple as Newton’s method used to 
approximate roots of polynomials. The legend to Figure 39 explains four ways this can 
occur when using Newton’s method to find the roots of a polynomial. Analogous means 
of divergence occur when using automated methods to curve fit our data with the theory 
equations.  The possibility of divergence is compounded by the number of parameters. 
This is why the curve fitting was begun with a “by eye” method. Here, one 
manually enters parameters, and manually changes them, to try to produce curves that 
fall on the data points. Then, in principle, these can serve as seed parameters for 
automated fitting. Moving to the stage of automatic fitting seeded with “by eye” 
determined parameters will be an ongoing part of the project for future students.  
 
Figure 39: Newton method divergence. Some ways the Newton method can diverge 
when seeking roots of polynomials. Clockwise starting from top left: An inflection point 
can push the algorithm farther and farther from the root (where the graph crosses the x 
axis).  The algorism can get stuck in an oscillating cycle and never escape. The seed 
value inadvertently causes a jump towards another, undesired solution. A horizontal 
tangent can cause the algorithm to “shoot off” towards infinity. 
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Another factor related to data fitting is that the experimental data was rescaled so 
the maximum value of PA density or MDD was taken as 1.  This was done to normalize 
the PA and microarray data because we do not know the real concentration of PAs or 
the real concentration of mRNA levels, at least with the REL x-fold and CN x-fold 
datasets.  By normalizing them, we could seek curve fits that lay in the plane from (0,1), 
which is what was done above. However, the rescaling of the D and S estimates opens 
up the wider issue of deriving a rescaled form of the SIM and MIM versions of the 
theory. This is possible to do, and DeGracia, Huang, and Huang (2012) presented a 
rescaled version of the autonomous model. However, it is not within the scope of this 
Dissertation to undertake this task and is a subject for future students and future work.  
Nonetheless, the main point related to fitting results shown here is that, technically, we 
should have used such a rescaled version of the theory to be consistent with how the 
data was handled.  
To summarize, given that there was sparse sampling of the data and that the 
fitting task is complicated by the number of parameters and the need to avoid 
divergences, we can draw no firm conclusions from the fits shown in Figure 32 and 
Figure 33.  A conservative interpretation of the work displayed is that the theory is not 
inconsistent with the data, that the data generally has the qualitative form the theory 
leads us to expect, but the low sampling and other complexities means we cannot 
definitively say that the fitting shows our measures of D and S are adequate estimates 
of the theory variables.  
5.3 Fitting with the MIM 
The previous section describes the pitfalls of fitting that limit our interpretation of 
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the data fits shown in Figure 32 and Figure 33.  Being mindful of these limitations, we 
nevertheless discuss now the MIM fits show in Figure 33.  These fits imply that 
additional injuries are occurring endogenously in the post-ischemic brain. A striking 
aspect of the raw data before fitting (Figure 26) is the impression of multiple curves 
superimposed on each other. This impression is reinforced by the spline fits shown in 
Figure 26. Strictly speaking, if we knew nothing of the system being studied, we should 
ignore these impressions and be as objective as possible in finding a curve to fit the 
data, as discussed in the previous section. However, there is over 40 years of brain 
ischemia research and a tremendous amount of information is known about the detailed 
cellular and molecular changes in the brain after ischemia, and specifically in the 2VO 
rat model, a standard global ischemia model in the field for over 25 years.  
The first study of microarrays of ischemic brain was presented in 1999. Since 
that time a couple dozen studies have been reported. It is now understood that there 
are “waves” of gene expression that occur during the reperfusion period and that these 
“waves” correspond to the responses of neurons, glia, blood vessels, and the immune 
system, each following their own intrinsic time courses, which in turn our conditioned by 
the complex interaction of these cell types. The MaSigPro analysis (Figure 34 to Figure 
37, and Table 10) recapitulates much that has already been established in the field. 
Thus, the concept of multiple “waves” over time is already accepted in the field and 
roughly corresponds to what a MIM system describes. 
What is new is our ability to use the MIM as a theoretical lens through which to 
view the many studies of waves of gene expression after brain ischemia. The following 
are speculations using the theoretical lens provided by the MIM.  Said succinctly, the 
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MIM suggests that the tissue is injuring itself in a sublethal fashion as a way to respond 
to the initial ischemia injury. It is as if there is a built in post-conditioning response. 
Given all that is known of the biology, this is probably a combination of glial protective 
responses and the immune system responses. Application of the MIM suggests that 
these are working to effect a post-conditioning, sublethal insult designed to tip the 
system overall from a pro-death to a pro-survival state.  Additionally, we observed that 
we got decent curve fits using a 2-MIM for CA1 and a 3-MIM for CA3. This indicates a 
response is not occurring in CA1 that is occurring in CA3, and since CA3 survives, this 
response might be critical for elevating S enough to allow CA3 cells to overcome the 
ischemic damage.  These comments must remain speculative and tempered by the 
limitations of curve fitting discussed above.  However, if true, or on the right track, this 
would be a major insight on how tissue responds to injury. 
5.4 The importance of parameter determination 
The parameters obtained from the data fits are the most important part of this 
project.   The cD and D parameters describe global brain ischemia. The cD and S 
describe CA1 and CA3 as the cell types used in this experimental system. I is directly 
proportional to the minutes of ischemia and is the control parameter since we wish to 
see how the system behaves over a range of I vales. The other parameters n, v0, c1 and 
c2 provide information about the kinetics of injury in CA1 and CA3. Specifically, v0 is the 
multiplier of the rate of formation. c1 tells how the rate of formation varies with time. c2 
tells the constant multiplier for the decay rate. All of these parameters give insight into 
how the system dynamics behave. If these numbers could be determined in an 
individual patient, this would, in principle, allow us to arrange a therapeutic strategy 
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based on that patient’s specific condition. 
Knowing the system parameters allows us to solve the theory for all possible 
states of the system, since the theory allows us to calculate how D and S will behave at 
any duration of ischemia. Once the system parameters can be validated, it can provide 
a prognostic value that can predict the patient prognosis and condition on an each by 
each basis120. 
5.5 Therapeutic implication of the theory 
Our work is driven by the clinical failure of therapy for brain ischemia. The most 
important long-term question to arise from the data and parameters for CA1 and CA3 
time courses was: How can we apply this theory and results to therapy? Currently, 
many neuroprotectants are available to target against the specific damage mechanism 
in brain ischemia including excitotoxicity, apoptosis, inflammation, oxidative stress, 
blood-brain barrier disruption, apoptosis, or autophagy117. However, since most of all 
these agents are failed in clinical trial91, our theory suggests we can reevaluate these 
various drugs. The theory calculates a time course. But the system needs to be bistable 
to have successful therapy. It is the bistable injury values of I where we can apply the 
neuroprotection as calculated by bistability diagrams derived from specific input 
parameters that need to be experimentally determined. The theory suggests that the 
drugs may have failed either because it was not given at a bistable injury magnitude or 
it was given at a time in the time course too late to salvage the brain cells. Another 
question is how do we know the best time to give the drug or therapy?  By having this 
template of thinking, we can design experiments to determine which drugs are the best 
on each time course of the ischemic progression. We can go back and test many of the 
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drugs that have proven effective in the lab and determine over what ranges of I they are 
effective, with the aim of clinical usage on that population of patients. 
By having the bistability diagram and parameters that have been validated, there 
will be a chance to develop a machine that can derive some of the parameters directly 
from the patient condition and have pre-programmed other parameters experimentally 
measured, like cD, cS, D, S.. This machine can calculate the ischemic progression in 
the patient so that the doctor can decide whether the patient condition is effectively 
treatable or not. Since brain ischemia patients admitted to the hospital with many 
variability ischemic condition and previous health status or other concomitant illness 
such as diabetes or hypertension, all patients present with different and nuanced 
ischemic status. The treatment for brain ischemia patients need to be patient to patient 
basis which is known as personalized medicine. Our theory is automatically one of 
personalized medicine by allowing to calculate the specific trajectory and progression of 
injury in each by each patient. The machine would not only predict the ischemia status 
of the patient, but it would be able to calculate the best therapy that can be given to the 
patient.  This is why study of the MIM is so important. Therapy is a sublethal injury by 
the MIM, and it can all be calculated. Determining what parameters to use is the key to 
being successful to apply the model in the clinical circumstances. 
5.6 Future Direction 
The most important Future Direction for this project is to validate means to 
measure D and S, and then apply these methods to test the theory equations. In 
principle both steps could be accomplished by repeating the exact designs of Aims 1 
and 2 at a series of ischemia durations, for example, at 2, 5, 7, 10, 12, 15, and 20 min of 
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global brain ischemia.  The present study produced one pair of D and S time courses for 
each of CA1 and CA3 after 10 min global brain ischemia. The proposed study would 
produce seven pairs of D and S time courses for each of CA1 and CA3.  Such a design 
would directly test the theory. The goal would be to find a set of parameters that fit all 
seven pairs of time courses where the only parameter that varied was injury intensity, I. 
If this could be done, it would confirm the theory and indirectly, confirm the measures of 
D and S. However, as discussed above, the empirical measurement of S appears to 
require refinement, especially at early reperfusion when gene independent stress 
responses probably dominate the magnitude of S.  
There are many smaller goals for future directions that need to be pursued, some 
mentioned above. A next major step is to refine the curve fitting method by automatic 
means to curve fit that are capable of dealing with the divergence problems is some 
reasonable fashion. As stated, combining other omics technologies to estimate S, such 
as different forms of proteomics, or metabolomics to measure small organic 
metabolites, or lipidomics to measure damage and recover of lipid pools would help 
refine the estimates of both D and S. Finally, continued work on the theory is required.  
The SIM expressed in Eq. (17) is a nonautonomous differential equation. There is no 
general theory of nonautonomous differential equations as there is a general theory of 
solving linear ordinary differential equations.  The SIM needs to be studied thoroughly 
as was the original autonomous model (DeGracia et al 2012) to determine if the 
solutions of the SIM can be easily classified in a fashion analogous to the autonomous 
model.  
Another future direction is to study the theory in a cell culture system, using a 
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homogenous clonal population. This has the advantage of homogeneity as opposed to 
the brain regions studied here that, although approximately 80-90% neuronal, still 
consisted of heterogeneous tissue including blood vessels, white matter, and glia. The 
disadvantage of the cell culture system is that it loses the direct clinical relevance of the 
brain system used here. But the advantage is that is should provide a “cleaner” system 
for the purpose of curve fitting and, because of the cell homogeneity, might only need to 
fit the SIM and not the MIM.  
5.7 Conclusions 
It is concluded that the studies described here provide the tentative first steps 
towards a new and unified understanding of the dynamics of acute cell injury.  This 
understanding is not grounded in the biological specifics of any one injured system, but 
seeks to describe properties common to all injured systems and describe how injured 
systems either recover or die as a function of time. The pitfalls and limitations of the 
studies were given above and allow us to make only the most conservative conclusion 
that the results do not outright contradict the theory, and that they provide tentative 
evidence we are moving in the right direction.   
It took about 40 years for the current paradigm of molecular biology to ascend to 
dominance in biomedical research.  This paradigm has led to a prodigious amount of 
detailed biological description, but it hasn’t eradicated clinically-relevant acute injury 
states as perhaps originally hoped. By applying methods that have worked essentially 
flawlessly for 350 in physics, the perspective put forward in this Dissertation hopes to 
open new doors where biomedical researchers can emulate the successes of the 
physical sciences. Further, the view presented here depends critically on the detailed 
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molecular biology view point and, we hope, represents the next stage in our evolution of 
biomedical research, leading to a day when we can understand and control clinically 
relevant injuries with the same precision engineers build cars, airplanes, and buildings.  
When that time comes, medicine will serve an even greater role than it does today in 
eradicating pain and suffering, and bringing health to humans around the world.  
  
103 
 
APPENDIX A 
IACUC Protocol Approval Letter 
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APPENDIX B 
HSP70 Validation of Ischemia Model 
The following HSP70 Western blots are from cortical samples used to assess the 
ischemia surgeries for samples used for isolation of protein aggregates. Samples 
labeled with red font were excluded from the study. 
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The following HSP70 Western blots are from cortical samples used to assess the 
ischemia surgeries for samples used for isolation of total and polysomal RNA for 
microarrays. Samples labeled with red font were excluded from the study. 
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APPENDIX C 
Microarray Class Comparisons between Groups 
The tables of class comparisons between groups on the microarrays constitutes 
several hundred pages of tables and are not practical to include in this document. 
These tables are accessible through the internet at the following link:  
http://www2.med.wayne.edu/degracialab/CCA/index.html  
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This Dissertation is the first to estimate the variables D and S of the nonlinear 
theory of acute cell injury in hippocampal regions CA1 and CA3 using a rat model of 
global brain ischemia and reperfusion (I/R). D was estimated by quantifying protein 
aggregates using ubiquitin Western blotting. S was estimated by quantifying changes in 
polysomal mRNAs as measured by microarray chips. D and S time courses were 
sampled at 0.5, 8, 16, 24, 48, and 72 hrs of reperfusion after 10 min brain ischemia. 
CA1 dies and CA3 survives. The theory predicts D will be larger in CA1 and S in CA3. 
Area under the curves of the D and S time courses showed this to be true. Trajectories 
of D vs S qualitatively matched updated versions of the theory. However, quantitative 
fits gave nonlinear correlation coefficients in the range 0.7-0.8. It was concluded that the 
acquired data did not falsify the theory. However, inadequate sampling over the time 
course, and the underestimation of S by failing to account for non-transcription 
dependent stress responses prevented strong quantitative fits between the measured 
estimates of D and S and theoretical time courses. 
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